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2 Summary 
Phleboviruses, in the Phenuiviridae family within the Bunyavirales order, are important 
pathogenic arthropod-borne viruses (arboviruses), causing severe diseases in humans and 
domestic animals. Outbreaks are no longer limited to tropical and developing countries. Global 
trade, deforestation and global warming are reasons for the expansion of arthropod vectors, and 
the viruses they carry. The mosquito-borne phlebovirus Rift Valley fever (RVFV) spread from 
sub-Saharan parts of Africa over the entire continent and to the Arabic peninsula during the last 
two decades. As it already happened for other arboviruses (e.g. dengue virus), RVFV is now at 
risk of introduction into Southern Europe. Phleboviruses represent a risk to public health and 
agricultural productivity and must be taken seriously as potential emerging and reemerging 
pathogens. For humans, neither specific antiviral treatments nor vaccines are currently 
approved. 
Ideally, treating phlebovirus infection in humans, would target early virus-host cell interactions, 
preventing the release of the virus genome into the cytosol. Yet, the details of the entry 
pathways exploited by phleboviruses are mostly elusive, awaiting to be uncovered. For my PhD 
project, I used Uukuniemi virus (UUKV). UUKV is a validated biosafety level (BSL)-2 model 
for phleboviruses of higher biosafety classification such as RVFV. 
Our lab previously reported that UUKV enters human host cells by receptor-mediated 
endocytosis, transits Rab5-positive early endosomes and penetrates the cytosol from late 
endosomal compartments with a pH value around 5.4. With the aim to identify additional host 
factors involved in UUKV entry, two genome-wide siRNA screens were performed. In those 
screens, VAMP3 was identified to facilitate late endosomal penetration of UUKV. The v-
SNARE protein VAMP3 plays an important role in recycling endosome trafficking and the 
initiation of autophagy. In addition to VAMP3, several other autophagy-associated host factors 
were found as potential host factors in the siRNA screens for UUKV entry. The overall goal of 
my PhD project was to clarify the role of autophagy in phlebovirus entry and decipher the 
molecular mechanisms subverted by phleboviruses to penetrate human host cells. Therefore, I 
analyzed UUKV infection by flow cytometry and confocal microscopy approaches. 
Within my PhD project, I assessed numerous autophagy-associated proteins for their role in 
UUKV infection. I identified the autophagic factor Atg7 and the small GTPase Rab11a as 
important host factors for UUKV infection. Atg7 is known mainly for its function in 
autophagosome maturation. Rab11a regulates recycling endosome trafficking and is involved 
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in the initiation of autophagy. Addressing single steps of the virus entry process, I found that 
Atg7 and Rab11 specifically promote UUKV intracellular trafficking, while no effects were 
observed on other steps during early virus host cell interactions, i.e. binding or replication. 
Interestingly however, my results also indicate that Atg7 and Rab11 participate in UUKV 
infection in an autophagy-independent manner. 
In conclusion, this thesis expands our knowledge about entry of UUKV particles into human 
cells with a role of two more host factors, Rab11a and Atg7. Both proteins facilitate the 
transport of endocytosed viral particles from the plasma membrane to acidic endosomal 
compartments. Reaching these compartments is a critical step for acid-activated fusion and the 
subsequent release of the viral genome into the cytosol. Additionally, this work provides an 
indication of autophagy-independent functions of Atg7 in endosomal trafficking. The 
importance of Rab11a and VAMP3 in UUKV infection points towards a potential involvement 
of recycling endosomes in UUKV intracellular trafficking. UUKV represents a tool of choice 
to better understand the role of recycling endosomes in late endosomal trafficking, a function 
that remains elusive and is potentially exploited by other related and unrelated viruses. 
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3 Zusammenfassung 
Phleboviren aus der Phenuiviridae Familie in der Ordnung Bunyavirales sind wichtige durch 
Arthropoden übertragene Viren (Arboviren), die schwerwiegende Krankheiten in Menschen 
und Nutztieren verursachen. Krankheitsausbrüche sind nicht mehr auf tropische - und 
Entwicklungsländer begrenzt. Globaler Handel, Abforstung und Klimaerwärmung sind Gründe 
für die Ausbreitung von Arthropodenvektoren, und deren Viren. Das durch Zecken übertragene 
Phlebovirus Rift Valley fever virus (RVFV) breitete sich innerhalb der letzten zwei Jahrzehnte 
von Teilen Subsahara-Afrikas über den gesamten Kontinent und die Arabische Halbinsel aus. 
Es besteht nun das Risiko, dass RVFV, wie bereits andere Arboviren (beispielsweise Dengue 
virus), in Südeuropa heimisch wird. Phleboviren stellen eine Bedrohung für die öffentliche 
Gesundheit und die landwirtschaftliche Produktivität dar und sollten als potentielle neu- oder 
wiederaufkommende Pathogene ernst genommen werden. Momentan sind für Menschen weder 
spezifische antivirale Medikamente noch Impfstoffe zugelassen. 
Idealerweise würde die Behandlung von Phlebovirusinfektionen in Menschen das Freisetzen 
des viralen Genoms in das Zytosol verhindern. Bislang bleiben die Details über die 
Transportwege, die von Phleboviren genutzt werden, unbekannt und warten darauf entdeckt zu 
werden. Für mein Promotionsprojekt arbeitete ich mit Uukuniemi Virus (UUKV). UUKV ist 
ein in Laboren der biologischen Sicherheitsstufe 2 validiertes Modell für Phleboviren einer 
höheren Sicherheitsstufe, beispielsweise RVFV. 
Unsere Labor hat zuvor gezeigt, dass UUKV humane Zellen durch Rezeptoren-vermittelte 
Endozytose betritt, über Rab5-positive, frühe Endosomen in späte Endosomen gelangt, von wo 
aus es bei einem pH-Wert von etwa 5.4 in das Zytosol eintritt. Mit dem Ziel weitere 
Wirtsfaktoren zu identifizieren, die am Zelleintritt von UUKV beteiligt sind, wurden zwei 
genomabdeckende siRNA-Screens durchgeführt. In diesen Screens wurde VAMP3 
identifiziert, welches den Eintritt von UUKV von späten Endosomen erleichtert. Das v-SNARE 
Protein VAMP3 ist wichtig für den Transport von Recycling-Endosomen und die Einleitung 
von Autophagie. Neben VAMP3 wurden im siRNA-Screen weitere Autophagie-assoziierte 
Wirtsfaktoren als potentielle Wirtsfaktoren für den Zelleintritt von UUKV gefunden. Das 
übergreifende Ziel meines Promotionsprojekts war es, die Rolle von Autophagie im 
Phleboviruszelleintritt aufzuklären und molekulare Mechanismen, die von Phleboviren zum 
Eintritt in humane Zellen genutzt werden, zu entschlüsseln. Dazu habe ich UUKV-Infektion 
mit Durchflusszytometrie und konfokaler Mikroskopie analysiert. 
 vi 
Während meines Promotionsprojekts habe ich die Rolle zahlreicher Autophagie-assoziierter 
Proteine in Bezug auf  UUKV-Infektion untersucht. Ich habe den Autophagiefaktor Atg7 und 
die kleine GTPase Rab11 als wichtige Wirtsfaktoren identifiziert. Atg7 ist hauptsächlich 
bekannt für seine Funktion zur Reifung von Autophagosomen. Rab11a reguliert den Transport 
von Recycling-Endosomen und ist an der Initiation der Autophagie involviert. Durch das 
Analysieren einzelner Schritte des Viruszeintritts habe ich herausgefunden, dass Atg7 und 
Rab11 den intrazellulären Transport von UUKV-Partikeln begünstigen, während kein Effekt 
auf weitere Schritte während früher Viruswirtsinteraktionen festgestellt wurden, zum Beispiel 
Bindung und Replikation. Interessanterweise jedoch, deuten meine Ergebnisse darauf hin, dass 
Atg7 und Rab11 in einer Autophagie-unabhängigen Funktion an der UUKV-Infektion 
teilhaben. 
Zusammenfassend erweitert diese Dissertation unser Wissen über den Zelleintritt von UUKV-
Partikeln in humane Zellen um eine Rolle der beiden Wirtsfaktoren Rab11a und Atg7. Beide 
Proteine begünstigen den Transport endozytierter Viruspartikel von der Plasmamembran zu 
angesäuerten Endosomen. Das Erreichen von diesen Kompartimenten ist entscheidend für die 
durch niedrigen pH Wert aktivierte Membranfusion und die darauf folgende Freisetzung des 
viralen Genoms ins Zytosol. Zusätzlich weißt diese Arbeit auf eine Autophagie-unabhängige 
Funktion von Atg7 im Endosomentransport hin. Die Relevanz von Rab11a und VAMP3 für 
UUKV-Infektion weist auf eine Beteiligung von Recycling-Endosomen am Transport von 
UUKV-Partikeln hin. UUKV stellt ein Werkzeug zum besseren Verständnis der Rolle von 
Recycling-Endosomen für den Transport von späten Endosomen dar, eine bislang unbekannte 
Funktion, die möglicherweise von anderen verwandten und nicht verwandten Viren genutzt 
wird. 
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WT wild type 
x g fold gravitational force 
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7 Introduction 
7.1 Arboviruses – emerging agents of disease 
Out of the nineteen pandemic, epidemic diseases currently listed by the World Health 
Organization, a total of five are caused by arboviruses: chikungunya, Crimean-Congo 
hemorrhagic fever, Rift Valley fever, yellow fever and Zika virus. This emphasizes a high 
relevance with prevailing importance 1. 
Arthropod-borne viruses, abbreviated as arboviruses, share the common characteristic of a 
transmission cycle between vertebrate or plant hosts and arthropod vectors. Plant-specific 
viruses are transmitted by thrip vectors 2, whereas vertebrate-specific viruses are transmitted by 
hematophagous arthropods such as ticks, mosquitoes, midges, or sand flies. These vectors 
acquire arboviruses while feeding on a viraemic host. After viral multiplication, the viruses are 
transmitted to the next vertebrate host during a blood meal. Typically, a sylvatic transmission 
cycle from the vector to the vertebrate host is required for amplification and to maintain viral 
reservoirs. In wild animals, such transmissions rarely cause symptomatic diseases, due to the 
long term of coevolution. Transmission to humans or domestic animals on the other hand 
occurred less frequently, and no balanced relationships could be established. Therefore, 
arbovirus infections in humans or domestic animals can result in significant morbidity and 
mortality. A low level of viraemia, typical for dead-end hosts, does not allow further arboviral 
transmission. Chikungunya, dengue, yellow fever and Zika virus however, have adapted to 
humans as vertebrate hosts. Viral replication in humans is efficient enough to sustain human-
mosquito transmission 3,4. This increases the danger for these viruses to become endemic. 
Importantly, arbovirus transmission is not limited to vector transmission. Crimean-Congo 
haemorrhagic fever virus was transmitted by direct contact with blood of a viraemic patient 5. 
West Nile virus can be transmitted vertically 6, by blood transfusions 7 and organ donations 8. 
Rift Valley fever virus is stable as aerosol 9 and suggested to be transmitted via this route of 
exposure 10. 
A high population density accompanied with increasing exploitation of land disturbed the 
sylvatic arboviral transmission cycles and led to an increased exposure frequency of humans to 
arthropod vectors. Furthermore, globalization, including passenger traffic and trade, in 
combination with global warming, allowed vectors and viruses to spread easily and to broaden 
their geographic distribution. This results in geographic expansion of arboviral diseases and the 
establishment of arboviruses as endemic diseases, of which some cause severe pathology 
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including encephalitis (Rift Valley fever virus, La Crosse virus), severe hepatitis (dengue virus) 
and hemorrhagic fever (Crimean-Congo haemorrhagic fever virus) 4,11. 
Arboviruses are not a taxonomic classification, but rather define a super group including distinct 
viral families. Human-pathogenic members are comprised in the Flaviviridae, Reoviridae and 
Togaviridae families and the Bunyavirales order (more specifically in the Peribunyaviridae, 
Nairoviridae and Phenuiviridae families), and are responsible for a growing number of 
outbreaks worldwide 12,13. The medically most relevant arbovirus is dengue virus 
(Flaviviridae). Dengue virus is present in most tropical or subtropical countries and was 
estimated to be responsible for 60 – 140 million cases annually, ranging from mild fever to 
partially fatal dengue shock syndrome 14. Chikungunya virus (Togaviridae) and Zika virus 
(Flaviviridae) were both newly introduced into the Americas, followed by rapid expansion and 
outbreaks in 2013 and 2015 respectively 15,16. Crimean-Congo haemorrhagic fever virus 
(Nairoviridae) is endemic in Africa, Middle East, Europe (the Balkans) and Asia and causes 
systematic haemorrhages with a mortality rate between 10 and 40 % 17,18. Human-pathogenic 
isolates of the Phlebovirus genus within the Phenuiviridae family are described into more 
details in a separate chapter (chapter 7.2.2). 
Efficient vaccines against Yellow fever virus and Japanese encephalitis virus (Flaviviridae) 
were successfully developed. But the absence of further vaccines or specific, effective drugs 
for the treatment of human pathogenic arbovirus infections in combination with their potential 
to cause a public health emergency 19, urgently calls for comprehensive research and rapid 
development in the field of arboviruses. Ideally, drugs should target an early step in viral 
infection but unfortunately, little is known about arbovirus cell biology, the vector-to-human 
transmission and entry into mammalian cells. 
The topic of my PhD project are phleboviruses, many isolates of which are highly pathogenic 
in both human and domestic animals. My thesis aimed to shed light on the productive pathways 
used by these viruses to enter host cells, with a specific emphasis on the tick-borne phlebovirus 
Uukuniemi (UUKV). 
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7.2 Phlebovirus genus 
7.2.1 Taxonomy 
Most of the time in my PhD I told interested researchers as well as my friends and family that 
I am working on bunyaviruses. Since March 2017 this is no longer true. The family 
Bunyaviridae was promoted to a new order: the Bunyavirales 20. The rationale behind this was 
to create room to 1) correctly reflect the phylogenetic relationship to newly included members, 
e.g. previously unassigned genera Emaravirus and Tenuivirus and 2) be able to classify 
bunyavirus family members that could not be assigned to any genus due to established 
classification criteria 21.  
The Bunyaviridae family used to comprise five genera: Hantavirus, Nairovirus, 
Orthobunyavirus, Phlebovirus and Tospovirus. Except for the rodent-borne hantaviruses, the 
other four genera were arboviruses. Nairoviruses, orthobunyaviruses and phleboviruses are 
transmitted by the blood-feeding arthropods sand flies, mosquitos, midges or ticks, and the 
group of plant-infecting tospoviruses is transmitted by thrips. All are enveloped viruses with a 
trisegmented, single-stranded RNA genome 22. 
The new order Bunyavirales additionally comprises nonenveloped members i.e. members of 
the genus Tenuivirus, bisegmented members e.g. Wuhan millipede virus 2 and South Bay virus, 
and members with more than three segments i.e. Emaravirus and Tenuivirus (having 4 to 6 
segments) 21. Bunyavirales are currently comprised of twelve different families: Arenaviridae, 
Cruliviridae, Fimoviridae, Hantaviridae, Leishbuviridae, Mypoviridae, Nairoviridae, 
Peribunyaviridae, Phasmaviridae, Tospoviridae, Wupedeviridae and Phenuiviridae 23. The 
latter includes the genus Phlebovirus, which is this project’s focus. 
The Bunyavirales order is currently under frequent rearrangement 24,25. According to the latest 
taxonomy update the two former tick-borne phleboviruses severe fever with thrombocytopenia 
syndrome virus (SFTSV) and Heartland virus (HRTV) are now classified to the Banyangvirus 
genus 23,24. For convenience with the project presented here and recent publications, I have 
chosen to keep the previous 25 taxonomy nomenclature. 
 
7.2.2 Epidemiology of phleboviruses 
The Phlebovirus genus comprises a variety of emerging pathogens of which some cause severe 
symptoms. The mosquito-borne Rift Valley fever virus (RVFV) is spread in Africa and Saudi 
Arabia and a major pathogen in domestic animals causing hepatitis and abortion in ruminants 
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as cattle, sheep, and goats, and also severe disease with fever, haemorrhages and sudden death 
in camels. Infection in humans is mostly asymptomatic. Some cases develop renal failure, acute 
hepatitis, neurologic dysfunction and haemorrhages. These symptoms are associated with 50 % 
lethality 26,27. The tick-borne severe fever with thrombocytopenia syndrome virus (SFTSV) is 
another example. It was first reported in China 2009 and then also isolated in Japan, North 
Korea and South Korea. Infected humans suffer from thrombocytopenia, leukocytopenia and 
haemorrhages, these symptoms are associated with a lethality rate of 5-30 % 28–30. The closely 
related Heartland virus (HRTV) is another tick-borne pathogen first isolated in the United States 
in 2012 with symptoms similar to SFTSV 31,32. The sand fly-transmitted Toscana virus (TOSV) 
is endemic in North Africa and Europe, including Italy, Spain, and the south of France. Infection 
is generally asymptomatic but in some cases leads to meningoencephalitis 33,34. 
7.2.3 The model virus UUKV 
This project is focused on Uukuniemi virus (UUKV; order Bunyavirales, family Phenuiviridae, 
genus Phlebovirus). UUKV is transmitted by ticks belonging to the species Ixodes ricinus and 
Ixodes scapularis, and infects a wide range of vertebrate hosts as birds, humans, cattle and 
reindeers 35,36. To date UUKV is not associated with any disease in humans and therefore 
presents the advantage to be handled in biosafety level-2 (BSL-2) laboratories. Closely related, 
highly pathogenic phleboviruses such as the tick-borne SFTSV and HRTV have to be handled 
under BLS-3 or BLS-4 conditions. Due to easier handling conditions and the availability of 
established tools, UUKV is readily used as a model for the investigation of phleboviral host cell 
invasion. 
UUKV strain 23, used in our laboratory, was originally isolated from Ixodes ricinus ticks, 
collected in 1959 in Finland, and was first amplified in chicken embryo fibroblasts and 
thereafter in BHK-21 cells 35. UUKV infects a wide range of mammalian cells such as BHK-
21, HEK 293T, HeLa and Huh7 cells as well as Ixodes ricinus and Ixodes scapularis tick cell 
lines 37,38. In infected mammalian cells, UUKV replication is high, while there is little or no 
progeny release. An exception are BHK-21 cells that release high amounts of progeny and are 
therefore commonly used for UUKV particle production 37. HeLa cells do not release viral 
progeny 37. Hence they are useful to study viral entry because we are sure to assess only the 
first round of infection. While infected mammalian cells die after a couple of days, no 
cytopathogenic effect is detected in UUKV infected Ixodes ricinus tick cell lines 37–39, reflecting 
the lack of pathology in arthropod vectors 40.  
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7.2.4 Virion structure & genome organization of phleboviruses 
Phlebovirus particles are enveloped, roughly spherical with a diameter of 80 – 160 nm and a 
tri-segmented single-stranded RNA genome, which exclusively replicates in the cytosol of host 
infected cells (Figure 1a). All three genomic RNA segments have highly conserved 
complementary nucleotides at the 3’ and 5’ end. A panhandle structure is formed by base 
pairing of the termini. The viral genomic RNA is thus present in a noncovalently closed circular 
form 22. 
A minimum of four structural proteins are encoded on the three genomic RNA segments in a 
negative-sense orientation (Figure 1b). An RNA-dependent RNA polymerase (RdRp), required 
for viral replication in the cytosol, is encoded on the largest segment (L). The lack of 
proofreading activity in the viral polymerase is accompanied by a high mutation rate (in the 
range of 10-5-10-6 substitutions per nucleotide and replication) and thereby allows rapid 
adaptation to environmental changes – a feature that might enable phleboviruses to expand 
geographically and increase their host range. The medium segment (M) encodes a precursor 
polyprotein, which is processed into two envelope glycoproteins GN (amino-terminal) and GC 
(carboxy-terminal). Enzymatic processing is mediated by host cell proteases at the Golgi 
apparatus, where phleboviruses assemble and derive their lipid envelope from. The 
glycoproteins form spike-like protrusions on the lipid envelope, arranged in an icosahedral 
surface lattice in penton-hexon clusters and a T = 12 triangulation 41. GN and GC are crucial for 
viral attachment to host cells and membrane fusion. The smallest segment (S) codes for the 
nucleoprotein N, coating the viral RNA to protect it from degradation. One RdRp molecule is 
bound per panhandle structure of the viral RNA. Altogether the viral RNA, coated by N proteins 
and bound to RdRp make up the ribonucleoprotein (RNP). A unique feature of Bunyavirales in 
comparison to other enveloped viruses is the lack of a rigid capsid or matrix 22,42,43. 
In addition to the four structural proteins, phleboviruses encode a nonstructural protein S (NSS) 
on the S segment in positive-sense orientation. NSS is an important virulence factor 
44. In the 
case of RVFV, NSs has been shown, for example, to inhibit general host cell transcription, 
interferon-β expression and protein kinase R (PKR) function, counteracting innate immune 
response and facilitating viral translation 44. The M segment of phleboviruses transmitted by 
dipterans (sand flies and mosquitoes) encodes an additional nonstructural protein NSM that is 
part of the precursor polyprotein for GN and GC. NSM inhibits apoptotic cells death by inhibiting 
caspases 45 but is also proposed as the second factor of virulence in RVFV infection, after NSs 
46. 
Introduction 
6 
 
 
Figure 1: Phlebovirus structure scheme 
a) Phlebovirus structure: Phlebovirus particles are enveloped, roughly spherical and have a diameter of 80 – 160 
nm. The genomic RNA is trisegmented and the segments are termed according to their size, namely small (S), 
medium (M) and large (L) segment. They encode at least four structural proteins: the nucleoprotein N, the 
glycoproteins GN and GC, and the RNA-dependent RNA polymerase (RdRp)]. Adapted from 43. b) Genomic 
organization of the mosquito-borne Rift Valley fever virus (RVFV) and the tick-borne Uukuniemi virus (UUKV): 
The three segments of the viral RNA genome and their respective length are shown. mRNAs are represented by 
arrows (boxes at the 5’ end depict host cell-derived sequences) and gene products are indicated by colored boxes, 
including their molecular mass below. In addition to the structural proteins, the three genomic RNA segments code 
for up to two nonstructural protein, NSS and possibly NSM. The lack of NSM gene is a specificity of phleboviruses 
transmitted by ticks such as UUKV; all others encode the NSM protein. Nt = nucleotides. Adapted from 43,47.  
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7.2.5 Phlebovirus entry into mammalian cells 
Natural transmission of arboviruses to vertebrate hosts occurs during the arthropod’s blood 
meal. Virions are injected into the host dermis, where dendritic cells (DCs) and macrophages 
(Mφs) are among the first encountered cells. As obligate intracellular parasites, viruses require 
entry into the target cell’s intracellular environment to access the host cellular machinery for 
viral infection and replication. Viral entry can occur in a variety of mechanisms, depending on 
the host cell and virus. Viral fusion relies on numerous host cellular factors and processes, of 
which only a minor portion is identified and characterized. Phlebovirus entry into mammalian 
cells starts with binding to specific attachment factors or receptors and subsequent uptake via 
receptor-mediated endocytosis. Internalization is followed by endosomal trafficking to an 
acidified compartment for fusion of the viral envelope with the host endosome membrane, to 
release the viral genome into the cytosol (Figure 2A-C) 40. UUKV is an excellent surrogate for 
the most highly pathogenic members in the Phlebovirus genus. Recent studies revealed 
important advances in the study of phlebovirus infection using UUKV as a model 48. In the 
following chapter, the different entry steps of phleboviruses are introduced in more detail with 
a specific focus on UUKV entry. 
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Figure 2: Phlebovirus replication cycle 
A) Phlebovirus particles bind to the host cell membrane by interaction of the viral glycoproteins with different 
receptors, for example nonmuscle myosin heavy chain IIA (NMMHC-IIA), heparan sulfate (HS), dendritic cell-
specific intracellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) and liver/lymph node-SIGN (L-
SIGN). Phleboviruses are taken up through clathrin-mediated endocytosis (CME) or clathrin-independent 
endocytic pathways (CIE). Internalization of virions is promoted by Ribonuclease kappa (RNaseK). B) Virions 
traffic to acidic late endosomal compartments. GC membrane fusion activity is induced by the low pH level. Fusion 
of UUKV is promoted by vesicle-associated membrane protein 3 (VAMP3) and fusion of RVFV is inhibited by 
interferon-induced transmembrane proteins 2 & 3 (IFITM2 & IFITM3). C) Upon fusion of the viral envelope with 
the host vesicular membrane, the viral RNPs are released into the cytosol, where transcription and replication take 
place. D) In the cytoplasm viral nucleoprotein, RdRp and genomic RNA (gRNA) are synthesized and associate to 
form the RNP. The glycoprotein precursor protein is translated at the rough endoplasmic reticulum (ER) and 
cleaved into GN & GC by a signal peptidase. E) ER chaperones, binding immunoglobulin protein (BiP) and calnexin 
(CNX) participate in the quality control of GN & GC maturation. The protein-disulfide-isomerase (PDI) supports 
proper folding by disulfide bond formation and calreticulin prevents the export of misfolded GN & GC from the 
ER. F) GN/GC heterodimers are transported to the Golgi apparatus. During budding of virions into the Golgi 
apparatus, the cytoplasmic tail of GN associates with RNPs. G) Vesicles containing virus particles are believed to 
be transported to the plasma membrane from where virions would be released by exocytosis. DC = dendritic cell, 
Mφ = macrophage. Adapted from 48. 
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7.2.5.1 Phlebovirus receptors 
Binding of phleboviruses to the host plasma membrane strictly relies on surface-exposed 
receptors including proteins and polysaccharides on glycoproteins 49. The glycosaminoglycan 
heparan sulphate (HS) is a receptor for RVFV and TOSV 50–52. Nonmuscle myosin heavy chain 
IIA (NMMHC-IIA), expressed on plasma membranes of Vero cells and human umbilical vein 
endothelial cells (HUVECs), is involved in infectious entry of SFTSV 53. 
A common receptor for the phleboviruses Punta Toro virus (PTV), RVFV, SFTSV, TOSV, 
UUKV is the DC-specific intracellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), 
also termed CD209 54,55. In UUKV infection, DC-SIGN is not only employed for virus 
attachment but also for internalization, and thereby serves as an endocytic receptor 54. DC-SIGN 
is specifically expressed on immature dermal DCs, specialized in capturing pathogens and 
antigen presentation 56. The location of these DCs coincides with the anatomical site of 
arbovirus introduction into mammalian hosts, i.e. the skin dermis. Furthermore the calcium-
dependent (C-type) lectin DC-SIGN binds high mannose and fucose N-glycans, typical insect-
derived glycoproteins 57, rendering DC-SIGN an interesting candidate receptor for 
phleboviruses. Indeed, human peripheral blood mononuclear cells (PBMC)-derived immature 
DCs are sensitive to RVFV and UUKV infection 54. 
The closely related liver/lymph node-specific intercellular adhesion molecule-3-grabbing 
nonintegrin (L-SIGN) is specifically expressed on human liver sinusoidal endothelial cells 
(LSECs). Like DC-SIGN, L-SIGN is a C-type lectin and recognizes high mannose N-glycans 
58. L-SIGN serves as a receptor for RVFV, SFTSV, TOSV and UUKV 55,59. In contrast to the 
endocytic receptor DC-SIGN, L-SIGN has been shown to only serve as an attachment factor 59. 
SFTSV infection depends on a third C-type lectin, the liver and lymph node sinusoidal 
endothelial cell C-type lectin (LSECtin) 60. LSECtin is expressed on LSECs, dendritic cells and 
macrophages 61,62 and recognizes mannose, N-acetylglucosamie and fucose 62. The three lectins 
DC-SIGN, L-SIGN and LSECtin play an important role in pathogen recognition and cell 
adhesion and, might be subverted by phleboviruses and other arboviruses to promote infection 
and facilitate virus spread 63. 
7.2.5.2 Uptake 
To enter a target cell, phleboviruses rely on the uptake into an endocytic pathway (Figure 2A). 
Virion receptor-interactions are an important prerequisite for viral internalization. The use of 
fluorescently labeled UUKV particles in combination with enhanced green fluorescent protein 
(eGFP)-tagged DC-SIGN allowed the visualization of virus receptor interactions 54. This was 
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the first time, that virus-receptor interactions were visualized live, making this system a useful 
model to study virus-receptor interactions in general. Cell-bound UUKV particles recruit  
DC-SIGN to their contact site and create a receptor-rich domain, important for membrane 
curvature and efficient receptor-mediated signal transduction, together resulting in virus 
internalization 49,54. 
Sequence motifs at the cytosolic tail of receptors serve as docking sites for specific adapter 
proteins and define the endocytic pathway, into which viral particles are taken up. One example 
is the dileucine (LL) motif at the cytosolic tail of the UUKV endocytic receptor DC-SIGN 59. 
The LL motif is an internalization signal 64 and known to mediate uptake into clathrin-coated 
vesicles 65. In addition to clathrin-mediated endocytosis, lipid raft-mediated endocytosis and 
phagocytosis have been proposed as internalization processes of DC-SIGN 57,64,66,67. 
Furthermore, glycosylation patterns of cargo are important for receptor recognition and 
intracellular signaling. DC-SIGN is reported to activate different intracellular signaling 
pathways according to the recognized carbohydrates 68,69. The differing glycosylation pattern 
of mammalian and arthropod cell-derived UUKV particles 38, could hence influence the utilized 
endocytic route.  
Electron microscopy-based studies show some UUKV particles in clathrin-coated vesicles and 
UUKV infection is not significantly reduced in absence of the clathrin heavy chain, indicating 
that the virus is mostly internalized through clathrin-independent mechanisms (Figure 3) 37,54. 
The details of UUKV uptake mechanisms remain to be defined. SFTSV, and also vesicular 
stomatitis Indiana virus pseudotyped with SFTSV glycoproteins GN and GC (rVSV-SFTSV), 
are internalized in a clathrin-dependent manner (Figure 3) 55,70. In the case of RVFV, three 
different internalization pathways have been proposed, each for different virus strains. While a 
nonspreading RVFV strain was shown to rely on clathrin for entry 71, the vaccine strain MP12 
was suggested to be internalized by macropinocytosis by a first study 72 and later through 
caveolin-dependent mechanisms by a second work (Figure 3) 73. Harmon and colleagues 
additionally report an independence of MP12 on clathrin-mediated endocytosis and 
macropinocytosis 73. Various outcomes could result from the use of different virus strains and 
cell models. Together these studies most likely reflect the ability of viral particles to use diverse 
internalization mechanisms. The use of certain viral receptors and uptake mechanisms influence 
in part the capacity of viruses to infect specific cell types and tissues. The ubiquitous 
transmembrane protein ribonuclease kappa is an additional factor involved in the internalization 
of RVFV MP12 74 but its specific function remains to be uncovered (Figure 2).  
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Figure 3: Phlebovirus endocytosis into mammalian cells 
Phlebovirus internalization follows several endocytic pathways, involving many host cellular factors as adaptor 
and coat proteins. RVFV = Rift Valley fever virus, SFTSV = severe fever with thrombocytopenia syndrome virus, 
UUKV = Uukuniemi virus. Adapted from 43. 
 
7.2.5.3 Intracellular trafficking 
Upon internalization, phleboviral particles are sorted into the endocytic system to traffic 
towards an acidic endosomal compartment for membrane fusion and subsequent viral genome 
release into the cytoplasm. Fusion of RVFV, SFTSV and UUKV envelope with the host 
endosome membrane strictly relies on a low pH (pH 5.7, 5.6 and 5.4 respectively), 
characteristically found in late endosomal compartments (Figure 4) 37,70,71. In line with the low 
pH-dependence, phleboviruses are highly sensitive to drugs, neutralizing the endosomal pH 
including the lysosomotropic weak bases ammonium chloride and chloroquine as well as 
inhibitors of the vacuolar H+ ATPases concanamycin B and bafilomycin A1 
37,54,55,71,73. 
Cargo can access acidic endosomal compartments by following the classic endocytic pathway 
from early endosomes (EEs) to multivesicular bodies (MVBs) and then late endosomes (LEs) 
that fuse with lysosomes (LYs) to form endolysosomes. MVBs are formed by endosomal 
sequestration and formation of intraluminal vesicles (ILVs). Rab proteins (small GTPases) are 
important factors that regulate endosomal trafficking and maturation. Rab5-positive EEs 
undergo conversion to Rab7-positive LEs, which finally fuse with LAMP1-positive LYs. A 
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continuously decreasing pH value in the luminal environment of endosomes is reached by 
vacuolar H+ ATPases concomitantly with endosomal maturation 75. To assess how 
phleboviruses reach fusion-competent compartments, trafficking within this classic endocytic 
pathway was investigated. Phleboviruses are proposed to transit Rab5-positive early endosomes 
(Figure 4). Studies with constitutively active or dominant negative Rab5 mutants as well as 
confocal microscopy imaging clearly show that UUKV relies on entering Rab5-positive early 
endosomes 37. Also rVSV-SFTSV and SFTSV were detected in Rab5-positive vesicles but 
functional studies with e.g. Rab5 mutants remain to be performed for this virus 70,76. 
A series of results indicates that phleboviruses can be classified as late-penetrating viruses, a 
group of viruses entering host cells through late endosomal compartments 77. In accordance 
with the acidic pH-dependence described above, RVFV and UUKV penetrate host cells 20 – 
40 minutes post infection (mpi), the time period required for late endosomal maturation (Figure 
4) 37,71. Also SFTSV fuses 15 – 60 mpi 70. During late endosomal maturation, LEs traffic along 
microtubules 78. UUKV and SFTSV are sensitive to the microtubule-depolymerizing agents 
colcemid and nocodazole, respectively, indicating an importance of late endosomal mobility 
along microtubules for viral infection 37,70. Histone deacetylase 8, participating in endosome 
maturation and microtubule organization, is an additional host factor involved in UUKV entry 
79. 
Even though phleboviruses are considered late penetrating viruses, the function of Rab7-
positive late endosomes in infection remains elusive. Life-cell imaging and confocal 
microscopy studies demonstrate the presence of UUKV in Rab7-positive late endosomes and 
LAMP1-positive lysosomes. But while constitutively active Rab7 mutants increase UUKV 
infection, dominant negative Rab7 mutants do not modify UUKV infection 37. Either there is 
no effect of the dominant negative Rab7 mutant or UUKV does not rely on Rab7-positive late 
endosomes to reach acidic compartments for fusion. Transmission electron microscopy and 
confocal microscopy-based studies identified SFTSV in late endosomal compartments and 
revealed an increase in colocalization with Rab7 in Vero E6 (African green monkey kidney) 
cells 30 – 60 mpi 70. Drake and colleagues, however could detect no or only little colocalization 
between rVSV-SFTSV and Rab7 in A549 (human lung) and U-2 OS (human osteosarcoma) 
cells 20 mpi and 40 mpi, respectively 76. Functional studies in Rab7-silenced cells for example 
remain to be performed to determine the importance of Rab7 in SFTSV infection. The vesicle 
associated membrane protein 3 (VAMP3) belongs to the family of v-SNARE fusion proteins 
and is an important host cellular factor required for late penetration of UUKV 80. 20 minutes 
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post infection, when viral particles start to colocalize with Rab7-positive late endosomes 37, 
colocalization of UUKV and VAMP3 also reaches a maximum 80. 30 mpi UUKV and VAMP3 
can be detected in LAMP1-positive late endosomes or endolysosomes in the nuclear periphery. 
Silencing of VAMP3 significantly reduces colocalization between UUKV and LAMP1, 
indicating that VAMP3 aids trafficking to late endosomal and lysosomal compartments. The 
endogenous function of VAMP3 in relation to its specific function in UUKV infection is further 
discussed in chapter 7.3. 
 
 
Figure 4: Phlebovirus intracellular trafficking 
This graph shows vesicles of the endocytic pathway and locations for viral penetration are indicated by brackets. 
The arrows above indicate the time (Δt), cargo requires to traffic from the plasma membrane and the pH level of 
the different endosomes. EE = early endosome, MVB = multivesicular body, LE = late endosome, LY = lysosome, 
ILVs = intraluminal vesicles, µtubules = microtubules. Adapted from 43. 
 
7.2.5.4 Fusion 
The final step of the entry process is the release of the viral genome into the host cytosol by 
fusion between the viral envelope and the host endosomal membrane. Fusion is driven by the 
two envelope glycoproteins GN and GC. For RVFV and UUKV acidification is sufficient to 
trigger fusion 71,81. In other cases additional cues, such as receptor interactions or proteolytic 
cleavage of viral glycoproteins or target membrane lipids, are a prerequisite for fusion 82. 
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SFTSV for example is proposed to rely on serine protease-mediated proteolytic cleavage of 
envelope glycoproteins for fusion 55. Liposome-based approaches demonstrate that RVFV and 
UUKV fusion at an acidic pH require the presence of bis(monoacylglycerol)phosphate (BMP) 
in the target membrane 81,83. BMP is an anionic lipid exclusively located in the inner membrane 
of LEs and LYSs 84. SFTSV late entry steps (during intracellular trafficking or fusion) and 
HRTV infection rely on the enzymatic activity of glucosylceramide synthase (UGCG) 76. 
UGUC initiates de novo biosynthesis of glycosphingolipids in the Golgi apparatus by 
synthesizing glucosylceramide 85. Interestingly, an accumulation of glucosylceramide enhances 
SFTSV infection 76, suggesting that a specific glycolipid composition in the targeted membrane 
is important for SFTSV infection. 
Fusion itself is a process in which a fusion protein inserts a hydrophobic domain into the target 
membrane to bring the viral envelope and the host membrane lipid bilayers into close proximity. 
Juxtaposed membranes are fused to allow the viral core to escape into the host cellular cytosol 
and finally infect the cell. Fusion proteins are assigned, at least, to three structurally different 
classes (class I, II and III), undergoing analogous functional transitions 82,86,87. RVFV GC 
(prefusion structure) and SFTSV GC (postfusion structure) show a close structural resemblance 
and exhibit 25 % sequence identity. Both glycoproteins are classified class II fusion proteins, 
catalyzing virus particle-host membrane fusion 88,89. GC glycoproteins are organized in three 
domains with a hydrophobic transmembrane domain and a fusion loop. Halldorsson and 
colleagues resolved the structure of RVFV GN and the RVFV GN-GC heterodimer and proposed 
the following fusion mechanism 83. At a neutral pH GN & GC form heterodimers. In this 
prefusion state, GN shields the fusion loop of GC, which is buried within the structure (Figure 
5i). Low pH is suggested to be perceived by GC histidine residues 
71,88. A drop in pH and 
exposure to the target membrane lead to a conformational change of GC, followed by GN 
moving to the side. As a consequence, the hydrophobic fusion loop is exposed, followed by its 
insertion into the host membrane (Figure 5ii). The GN-GC heterodimers dissociate, allowing 
redistribution of extended GC monomers on the viral membrane (Figure 5iii). The juxtaposed 
membranes fuse and GC forms stable postfusion trimers, burying the fusion loop in the just 
fused lipid bilayer (Figure 5iv). This process can be counteracted by host cell proteins. For 
example, by inserting in endolysosomal membranes, IFITM2 and IFITM3 change the biological 
properties of the target cell membrane and block RVFV fusion. This is a known innate defense 
mechanism against viral invasion (Figure 2B) 90. 
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Figure 5: RVFV fusion mechanisms 
Consecutive steps of viral fusion are schematically represented from left to right. i) Pre-fusion complex made up 
of GN-GC heterodimers. ii) At a fusion-permissive pH level GC changes its conformation and GN moves to the side, 
resulting in the exposure of the fusion loop and its insertion into the host membrane. iii) GN dissociates and the 
extended GC redistributes in the viral envelope. iv) The endosomal and viral membrane merge, whereupon GC 
forms postfusion trimers, which embed the fusion loops in the fused membrane. GC domain I is colored in red, 
domain II in yellow, domain III in blue with the transmembrane domain as a blue rectangle and the fusion loops 
in orange. GN domain A is colored in teal, domain B in green and the β-ribbon in purple. The lipid bilayer is 
represented in grey, with the head group in dark grey and the acyl chains in light grey. Adapted from 83. 
 
Structural similarities between RVFV and SFTSV GN and GC proteins suggest that the 
described fusion mechanism might be similar among different viruses in the Phlebovirus genus 
83,88,89,91. RVFV fusion mechanisms are analogous to those reported for alpha- (Togaviridae 
family) and flaviviruses (Flaviviridae family) 92,93, suggesting a conservation of the fusion 
mechanisms between these arboviruses. Once the viral core accesses the host cellular cytosol, 
virus replication begins. 
 
7.2.6 From replication to the release of infectious viral particles 
Upon fusion, viral RNPs (vRNPs) are released into the cytoplasm for transcription and 
replication. Due to a lack of capping ability, other Bunyavirales, for example the 
orthobunyavirus La Crosse, were reported to start transcription with a cap-snatching 
mechanism. In this process 5’ caps from host mRNAs are cleaved off by the endonuclease 
domain of the viral RdRp 94. The snatched cap is then used as a primer for transcription of viral 
RNA at the rough endoplasmic reticulum (rER). Transcription, also of RVFV and UUKV, is 
initiated with a prime-and-realign strategy to elongate short snatched primers 95,96. After 
priming, incorporation of a few nucleotides, the extended cap mRNA moves backwards and 
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realigns to the template. This is possible due to terminal repeat sequences. For transcription 
termination, a hairpin structure, formed by inverted complementary RNA sequences, is 
supposed to cause dissociation of the viral polymerase in the phlebovirus Punta Toro virus 
(PTV) 97. In a transcription-coupled translation mechanism phleboviral proteins are 
synthesized. 
Replication takes place in the cytosol and is driven by vRNPs. The terminally associated RdRp 
first synthesizes a complementary RNA strand (cRNA), to which newly synthesized N and L 
proteins attach to form a complementary RNP (cRNP). Accordingly, cRNPs then direct 
synthesis of progeny vRNPs. The vRNP reproduction process is amplified by using the progeny 
vRNPs as templates for cRNPs to produce more vRNPs. Viral transmembrane glycoproteins 
traffic from the rER to the Golgi apparatus whereto vRNPs also move. Together vRNPs and 
viral glycoproteins assemble to progeny virus particles by budding into the ER-Golgi 
intermediate compartment (ERGIC) or the Golgi apparatus 98. As a final step newly produced 
viral particles are believed to be released through exocytosis of secretory vesicles 13. 
 
7.3 siRNA based screen for UUKV host factors 
To identify novel factors involved in UUKV infection and thereby shed light onto the early 
virus-host cell interactions, a genome-wide siRNA screen was performed in our lab 80. The 
human cell line HeLa expressing the UUKV receptor, DC-SIGN, was used in this approach 99. 
Those cells were therefore highly susceptible to UUKV infection 59. 
An automated fluorescence microscopy-based approach was chosen to quantify cells with 
newly synthetized nucleoprotein N to monitor viral replication. Thereby, host cellular factors 
involved in UUKV entry and replication up to N protein translation could be identified. After 
screening two independent human genome-wide siRNA libraries (one from Dharmacon and the 
second from Qiagen), the fusion protein VAMP3 appeared as potential host cellular factor in 
both siRNA screens. In-depth characterization revealed VAMP3 as an important factor for late 
penetration of UUKV. VAMP3 mediates sorting endosome fusion with REs and regulates 
constitutive exocytosis of integrins, transferrin and the transferrin receptor to the plasma 
membrane 100,101. VAMP3 also mediates fusion of EEs with the TGN to transport cholera toxin 
and ricin 102, or fusion of LEs with the TGN for retrograde transport of the mannose 6-phosphate 
receptors 103. VAMP3 also plays a role in the initiation of autophagy 104 and fusion between 
MVBs and autophagosomes 105, thereby bridging the endosomal and autophagosomal pathway 
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106. Interestingly, two key autophagy proteins WIPI1 and FIP200 (also termed RB1CC1) were 
identified as potential host cellular factors 80. In addition, the small GTPases Rab1b and Rab11a 
were identified as potential host cellular factors 80. Besides the role of Rab1b in ER-Golgi 
trafficking 107 and the role of Rab11a in recycling endosome trafficking 108 both proteins have 
reported functions in the autophagic pathway 109,110. Together those data led us to make the 
hypothesis that the autophagic pathway may play a role in UUKV infection. 
 
7.4 Autophagy 
7.4.1 Historic cornerstones of autophagy research in short 
Christian de Duve, Nobel Prize laureate for lysosome discovery, defined and coined the term 
autophagy (Ancient Greek, “self-eating”) in 1963. He described autophagy as a process by 
which a cell self-engulfs portions for lysosomal degradation. During starvation cells can reuse 
parts of their own substances for “fuel” and “renewal of their own constituents”. A limiting 
membrane keeps autophagy localized to prevent self-damage 111. This principle still holds true 
today. Beyond, numerous additional functions of the autophagy pathway and concise 
underlying molecular mechanisms have been defined over the intervening years. Two 
cornerstones to define the autophagy process on a molecular level were the identification of the 
today termed autophagy-related genes (Atgs), required for autophagy in yeast by the Nobel 
Prize laureate Yoshinori Ohsumi’s lab 112 and the discovery of two essential linked protein 
conjugation systems for autophagosome formation by Noboru Mizushima and colleagues 113. 
7.4.2 Functions of autophagy 
Autophagy is a basic intracellular process for the degradation of cytoplasmic constituents, 
mediated by lysosomes. The first discovered function of this catabolic process is to provide 
nutrients and energy-rich molecules under suboptimal (e.g. starvation) conditions. Beyond, the 
overall purpose of autophagy is to maintain cellular integrity and metabolic homeostasis – vital 
cellular processes. To these ends, a variety of selective autophagy pathways exist that remove 
surplus or potentially harmful intracellular components. Mammalian cells specifically target 
nonfunctional cellular constituents such as aggregated or misfolded proteins, storage nutrients 
(glycogen or lipid droplets) and dysfunctional organelles such as peroxisomes, mitochondria or 
parts of the ER, as well as for example bacterial or viral intruders 114. 
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Disturbed autophagy or malfunctioning autophagy related proteins impact human health and 
are associated with a broad variety of human pathophysiological conditions such as cancer, 
metabolic disorders, aging, infection, inflammation and neurodegenerative diseases 114. 
 
7.4.3 Autophagy processes in mammalian cells 
In mammals, autophagy can be categorized into chaperone-mediated autophagy (CMA), 
microautophagy, and macroautophagy, according to how substrates are delivered into the 
lysosomes. 
CMA uses chaperones to move cytosolic components, mostly aggregated or unfolded proteins, 
into the lysosome. The chaperone Hsc70 (a heat shock cognate protein of 70 kDa) recognizes 
proteins via a CMA-targeting pentapeptide motif (KFERQ). Hsc70 guides its cargo to the 
lysosome, where it is recognized by the receptor LAMP2A (lysosome associated membrane 
protein type 2A) and directly translocated across the lysosomal membrane for degradation by 
lysosomal acid hydrolases (Figure 6) 115. Microautophagy describes the lysosomal uptake of 
proteins and organelles by invaginations at the sequestering membrane (Figure 6) 116. 
During macroautophagy, cargo delivery to the lysosome is mediated by specific transport 
vesicles, the autophagosomes. A double-membrane is formed within the cytosol (termed 
phagophore or isolation membrane), engulfing cytoplasmic constituents. Once this membrane 
is sealed, the newly formed autophagosome fuses with lysosomes to form an autolysosome, 
resulting in the degradation of the cargo (Figure 6). Autophagosome biogenesis as wells as 
autophagosome-lysosome fusion are regulated by Atg proteins and a variety of additional 
proteins, including small GTPases, SNARE (soluble NSF attachment protein receptor) and VPS 
(vascular protein sorting). The focus of this study is on macroautophagy, hereafter referred to 
as autophagy for convenience, and discussed in more detail in the following chapter. 
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Figure 6: Autophagy processes in mammalian cells 
Autophagy is an intracellular degradation pathway leading to lysosomal degradation. Macroautophagy involves 
the formation of a cytosolic double membrane, the phagophore, sequestering surplus or harmful cellular contents. 
The mature autophagosome is encompassed by the double membrane and fuses with the lysosome for cargo 
degradation. Chaperone-mediated autophagy describes a process, in which cytosolic proteins are recognized via 
the peptide motif KFERQ by a heat shock cognate protein of 70 kDa (Hsc70). The lysosomal associated membrane 
protein type 2A (LAMP2A) recognizes the Hsc70 cargo complex and together with other proteins translocates the 
cargo into the lysosome for degradation. Microautophagy is a process during which cytosolic content is directly 
internalized into vesicles from the lysosomal membrane. Adapted from Novus Biologicals 
(https://www.novusbio.com/research-areas/autophagy). 
 
7.4.4 The macroautophagy process on a molecular level 
7.4.4.1 Regulation of the autophagic pathway 
Besides a basal level of autophagy, various stimuli, e.g. starvation, stress or infection can 
upregulate autophagic activity. The nutrient-sensing kinase MTORC1 (mechanistic target of 
rapamycin complex 1) and the energy-sensing kinase AMPK (AMP-activated protein kinase) 
differentially phosphorylate and regulate the most upstream key autophagy regulator, the ULK1 
complex 117. This complex consists of ULK1, Atg13, FIP200 and Atg101. MTORC1 is active 
when nutrient levels are replenished 118 and inactivates ULK1 by phosphorylation of ULK1 
serine 757 117. This phosphorylation blocks AMPK interaction with ULK1 and thereby prevents 
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autophagy induction. AMPK becomes active upon ATP-depletion and inhibits MTORC1 by 
phosphorylation of its subunit RAPTOR 119. AMPK-mediated phosphorylation of ULK1 serine 
317 and serine 777 results in the activation of the ULK1 complex, and induces autophagy 117. 
 
7.4.4.2 Initiation of autophagy 
Autophagy initiation involves the translocation of two protein complexes, namely ULK1 (Unc-
51 like autophagy activating kinase 1) and PI3KC3-C1 (class III phosphatidylinositol 3-kinase 
complex 1), to specific sites at the ER. These translocations lead to the production of the lipid 
phosphatidylinositol-3-phosphate (PI3P), in turn recruiting effectors for phagophore formation. 
ULK1 is mostly cytosolic and can form a heterotetrameric complex with Atg13 and FIP200, 
that increase the kinase activity and stabilize ULK1; and Atg101, promoting stabilization of 
ULK1 and Atg13 118,120 (Figure 7). Upon autophagy induction, the ULK1 complex is suggested 
to translocate to ER-mitochondria contact sites and Atg9-containing autophagy-specific ER exit 
sites, termed omegasomes 121,122. The ULK1 complex remains anchored to the omegasome until 
the phagophore is formed and growing, and is then recycled to the cytoplasm 123. 
Phagophore formation is initiated by PI3KC3-C1, comprising the catalytic subunit VPS34, 
VPS15 (or p150), Beclin 1 and Atg14L (Figure 7). Under basal autophagy conditions, BECN1 
was found to tether PI3KC3-C1 to microtubules by AMBRA1-mediated binding. Starvation 
disrupts microtubule association 124 and PI3KC3-C1 is recruited to phagophore initiation sites 
where ULK1 phosphorylates PI3KC3-C1 and activates VPS34 kinase activity 125. The 
membrane lipid phosphatidylinositol (PI) is then phosphorylated by the activated VPS34 to 
generate PI3P. The charged signaling lipid PI3P recruits proteins that exhibit specific motifs, 
for example FYVE or F/LRRG. The four mammalian WIPI proteins are important PI3P binding 
proteins, that monitor phagophore formation and growth 126–128. Puri and colleagues report that 
PI3P requires an additional protein, the small GTPase Rab11a, to specifically recruit WIPI2 to 
the phagophore formation site 129. In contrast to the current belief, that autophagy is initiated at 
the ER, the importance of the RE marker Rab11a suggests that REs serve as a platform for 
phagophore formation 129 (for more details on Rab11a see chapter 7.5.2). 
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7.4.4.3 Phagophore elongation 
Two ubiquitin-like conjugate systems, Atg12-Atg5-Atg16L1 and LC3-II are required for 
elongation of the phagophore and closure to form the autophagosome. 
In the first step of the ubiquitin-like conjugation process, Atg7 activates Atg12 (E1 step) 
followed by transfer to the conjugation enzyme Atg10 (E2 step). Atg12 is then conjugated to 
the substrate Atg5, subsequently forming a complex with Atg16L1. WIPI1 and WIPI2 are 
important to recruit the Atg12-Atg5-Atg16L1 complex to the omegasome and Atg12-Atg5-
Atg16L1 in turn recruits the second ubiquitin-like conjugate protein LC3 (microtubule-
associated proteins 1A/1B light chain 3). The C-terminal part of the cytosolic LC3 is cleaved 
by the cysteine protease Atg4. This processed LC3 is called LC3-I. LC3-I is then activated by 
Atg7 (E1 step) and subsequently transferred to Atg3 (E2 step). Finally, the Atg12-Atg5-
Atg16L1 complex mediates LC3-I lipidation by conjugation to the membranous 
phosphatidylethanolamine (PE) via the exposed glycine (E3 step) 130. LC3-PE, most commonly 
called LC3-II is anchored to the inner and outer autophagosome membrane and thereby 
represents a robust marker for autophagosomes and autophagy. The characteristic conversion 
of LC3-I to LC3-II can be used to monitor autophagic flux by immunoblotting. Recruitment of 
fluorescently labeled LC3 from the cytosol to the autophagosome upon lipidation and the 
concomitant redistribution from a diffuse cytosolic distribution to the formation of punctate 
structures corresponding to autophagosomes, is frequently used to visualize autophagosome 
formation under a fluorescence microscope 131. 
Functionally, LC3-II is an important receptor for substrate recruitment to the extending 
phagophore. Recruitment to the inner phagophore membrane results in cargo uptake into the 
autophagosome. Anchor proteins, such as p62 or NBR1, bind ubiquitinated proteins and move 
these to the phagophore by binding LC3-II with their LC3-interacting region (LIR) 132,133. LIR-
dependent recruitment of NDP52 to the outer membrane is suggested to regulate transport of 
autophagosomes along actin filaments by NDP52-myosin VI interactions 134. LC3-II also 
regulates autophagosome-lysosome fusion, by recruiting PLEKHM1 135 (see chapter 7.4.4.4). 
Upon fusion with the lysosome LC3-II is cleaved off the outer membrane by Atg4 and degraded 
by lysosomal enzymes on the inner leaflet 131. 
The source of membrane for phagophore elongation is still under debate. Various cellular 
organelles, including ER, ERGIC, Golgi apparatus, mitochondria as well as the plasma 
membrane are suggested to contribute membrane to the phagophore 136–140. Atg9, a 
transmembrane protein, is believed to deliver membrane parts or phospholipids from different 
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donor sources to the phagophore. The small GTPase Rab1b is present on these Atg9 positive 
vesicles and regulates autophagosome formation 141 (for more details on Rab1b see chapter 
7.5.1). At a basal autophagy level, Atg9 is located in the Golgi apparatus. Upon autophagy 
induction, Atg9 disperses into different compartments. During transient interaction with the 
phagophore, Atg9 is suggested to deliver membrane components to the forming phagophore 
142. Atg2 is required to complete phagophore closure, to eventually form the autophagosome 
143. 
 
7.4.4.4 Autophagosome-lysosome fusion 
Fusion between the autophagosome and lysosome (yielding autolysosomes), is mediated by 
PI3KC3 complex 2 (PI3KC3-C2). Similar to PI3KC3-C1, PI3KC3-C2 comprises the catalytic 
subunit VPS34, VPS15 and Beclin 1. In a mutually exclusive manner either Atg14L or UVRAG 
(UV-radiation resistance-associated gene protein) can bind, defining complex 1 and 2 
respectively 144. 
The adaptor protein termed pleckstrin homology domain-containing protein family member 1 
(PLEKHM1) is a Rab7 effector. PLEKHM1 simultaneously binds Rab7 and LC3-II and thereby 
bridges autophagic and lysosomal membranes 135. PLEKHM1 additionally recruits the tethering 
complex HOPS (homotypic fusion and protein sorting) 135. HOPS interacts with the SNARE 
fusion protein syntaxin 17 that mediates autophagosome-lysosome fusion 145. Syntaxin 17 only 
binds to the outer membrane of completed autophagosomes but not to the phagophore, therefore 
lysosomes only fuse with completed autophagosomes 146. Finally, the cargo is degraded by 
lysosomal acid hydrolases. 
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Figure 7: Molecular basis for mammalian macroautophagy 
In the first step the ULK1 complex (comprising ULK1, Atg13, FIP200, Atg101) is translocated to the phagophore 
initiation site, where it activates the class III phosphatidylinositol 3-kinase complex 1 (PI3KC3-C1) (comprising 
VPS34, Beclin 1, VPS15, Atg14) by phosphorylation. The activated protein kinase VPS34 produces 
phosphatidylinositol-3-monophosphate (PI3P). WIPI1 and WIPI2 have a PI3P as well as an Atg16L binding 
domain and mediates binding of the Atg12-Atg5-Atg16L conjugate to the phagophore initiation site. The Atg12-
Atg5-Atg16L complex enables LC3 conjugation to phosphatidylethanolamine (PE) in the phagophore membrane. 
LC3-PE is a receptor for autophagy substrates. PLEKHM1 binds Atg7 as well as LC3 and bridges the lysosome 
and the autophagosome. The subsequent autophagosome-lysosome fusion is mediated by the tethering complex 
HOPS, bound to PI3KC3-C2 (comprising VPS34, Beclin 1, VPS15, UVRAG), that recruits SNARE fusion 
proteins. PAS = preautophagosomal structure. Adapted from 147. 
 
7.4.5 Autophagy in viral infection 
Autophagy can participate in defending host cells from pathogen invasions. Xenophagy, a 
selective form of autophagy, specifically recognizes and targets intracellular microorganisms 
for degradation to autophagosomes 148. An innate immune response is initiated by autophagy 
after infection through activation of pattern recognition receptors (PRRs), inducing interferon 
production and secretion 149. Pathogen degradation within the autophagosome initiates an 
adaptive immune response in which viral antigens are delivered onto major histocompatibility 
complex I or II (MHCI/II) for presentation to T lymphocytes 149. Through ongoing evolutionary 
competition, however, viruses have evolved to circumvent the autophagy-mediated immune 
response and elimination, for instance by blocking key components of the autophagic pathway 
147. Several viruses even hijack and utilize autophagy for their own benefit, such as genome 
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replication or exocytosis of viral particles 147. A wide variety of distinct virus-autophagy 
interactions have been described, and were recently reviewed by 147,150–154. The following 
subchapters briefly describe the various virus-autophagy interactions, including those identified 
for the phleboviruses RVFV and SFTSV. 
 
7.4.5.1 Autophagy as an antiviral defense mechanism 
Autophagy plays an important role in mounting an innate immune response. An innate immune 
response is mediated by PRRs, including Toll-like receptors (TLRs), specifically recognizing 
pathogen-associated molecular patterns (PAMPs), resulting in induction of an antiviral 
interferon response. TLR7- as well as TLR9-induced interferon production in response to 
infection by Vesicular stomatitis Indiana virus (VSV) and herpes simplex virus type 1 (HSV-
1) respectively,  relies on the key autophagy protein Atg5 155,156. Moreover, TLR adapter 
proteins MYD88 and TRIF bind to Beclin1 to disrupt its inhibition by B cell lymphoma-2 
(BCL-2) and ultimately induce autophagy (Figure 7). In turn autophagy can selectively degrade 
TRIF to inhibit TLR signaling 157. The phlebovirus RVFV is suggested to induce a TLR-
mediated antiviral autophagy response 158. Autophagy is also suggested to have an antiviral 
function against SFTSV infection 159. 
Xenophagy, targets intracellular pathogens, such as bacteria and viruses, to the autophagosome 
for degradation. Some PRRs are xenophagy signaling receptors, e.g. p62, NBR1, NDP52 and 
optineurin and expose a cargo recognition domain (CRD) for specific recognition of pathogens, 
and an LC3-interacting region (LIR) for recruitment to the autophagosome. NDB52 for 
example possesses a CRD that specifically binds β-galactoside glycans, cytoplasmically 
exposed on pathogen-damaged endosomes, and thereby targets these endosomes to lysosomes 
for content degradation 160. Picornaviruses for example are recognized upon β-galactoside 
exposure but as a countermeasure recruit a host protein to block this detection and prevent 
autophagic degradation 161. 
LC3-associated phagocytosis (LAP) is a recently discovered selective autophagy pathway that 
acts independently on autophagosomes. In LAP, LC3 is conjugated to newly formed, pathogen 
containing phagosomes. Phagosome-lysosome fusion results in the formation of a 
phagolysosome inside which pathogens are degraded 162. 
Autophagy is also involved in generating an adaptive immune response. Adaptive immunity 
involves antigen presentation on MHC complexes to T lymphocytes. Autophagy mediates 
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processing of viral antigens as well as antigen delivery to MHC-I and MHC-II complexes 147. 
In addition, fusion between autophagosomes and MHC-II-containing vesicles results in the 
presentation of engulfed cytoplasmic proteins by MHC-II to CD4+ T cells 163. 
 
7.4.5.2 Evasion of the autophagy-mediated antiviral response 
To evade autophagy-mediated immune response and degradation, different viruses have the 
ability to block key autophagy proteins. HSV-1 and human cytomegalovirus (hCMV) express 
Beclin 1-blocking proteins to inhibit autophagy 164,165. Kaposi’s sarcoma-associated herpesvirus 
(KSHV) prevents LC3 processing by inhibiting binding to Atg3 166.  
 
7.4.5.3 Viruses exploit autophagy for their own benefit 
Multiple studies demonstrate that viruses utilize the autophagic machinery, parts of it, or single 
autophagy-related proteins for their benefit. Viral-autophagy modifications are diverse and 
happen during different steps of virus life cycles, from internalization to particle release. 
Ebola virus (EBOV, Filoviridae) particles are known to be internalized by macropinocytosis 
167. A recent study demonstrates that EBOV internalization depends on the autophagic proteins 
Beclin 1, Atg7 and LC3 due to LC3-II requirement for macropinosome biogenesis 168. 
Cellular entry of the two enveloped viruses Varicella zoster virus (VZV, Herpesviridae) and 
Influenza A virus (IAV, Orthomyxoviridae) highly depends on UVRAG. Besides its crucial 
role in autophagosome elongation, UVRAG is important for late endocytic transport. Infection 
prevents UVRAG-mediated late endosome fusion with the lysosome. VZV and IAV thereby 
evade lysosomal degradation 169. 
Various viruses utilize autophagosomes for replication purposes, e.g. members of the 
Picornaviridae, Coronaviridae and Flaviviridae families. Cytosolic double membrane vesicles 
provide a scaffold for the viral replication machinery and prevent detection of viral RNAs by 
innate immune sensors as well as degradation 147. The mosquito-borne dengue virus (DENV, 
Flaviviridae), for example, induces autophagy during infection 170. Silencing the key autophagy 
protein Atg5 impairs viral replication, indicating a proviral effect of autophagy on DENV 
infection 170. DENV nonstructural proteins and double-stranded RNA localize to LC3-labeled 
vesicles, thus autophagic membranes are suggested to serve as a platform for DENV replication 
171. Localization of the ribosomal protein L28 to dsRNA additionally points towards a 
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translational capacity 171. Lipophagy, a selective autophagic process for degradation of lipid 
droplets is also utilized to promote viral replication. DENV-promoted catabolism of lipid 
droplets provides free fatty acids and generates ATP (by β-oxidation) for viral replication 172,173. 
In addition to using autophagic membranes for replication, members of the Herpesviridae, 
Picornaviridae and Flaviviridae families can subvert the autophagic machinery for particle 
exocytosis 147. VZV (Herpesviridae), an enveloped dsDNA virus for example, is released from 
cells in single membraned LC3-II and Rab11a-positive vesicles. Fusion with the plasma 
membrane releases VZV particles from the cell 174. 
 
7.5 Rab GTPases: Regulators of cellular trafficking 
Membrane trafficking between multiple organelles of the eukaryotic cell is crucial for its 
existence. Rab GTPases, a family of small GTPases, ensure cargo delivery to the proper 
destination by defining membrane identity and controlling vesicle transport, including coat 
recruitment and uncoating, motility, fission, target selection and fusion. Humans express more 
than 60 different Rab proteins 175. 
Intrinsically soluble Rab proteins can only be anchored to a specific membrane upon 
prenylation by a Rab geranylgeranyl transferase (RabGGTase) (Figure 8.1). Within the target 
membrane, Rab proteins are then activated by guanine-nucleotide exchange factors (GEFs). 
The concomitant exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) 
enables binding of the active Rab proteins to effector proteins mediating downstream functions 
(Figure 8.2 & Figure 8.3). Finally, GTPase-activating proteins (GAPs) enhance the Rab 
protein’s intrinsic GTPase activity to hydrolyze GTP to GDP and terminate its function. 
Guanine-nucleotide-dissociation inhibitors (GDIs) recognize and extract GDP-associated Rab 
proteins from the membrane by shielding the hydrophobic geranylgeranyl group (Figure 8.4). 
Solubilized Rab proteins constitute a cytoplasmic pool for redelivery to another target 
membrane 176. Rab proteins are reversibly attached to vesicles of the endocytic and exocytic 
pathway. Activated Rab GTPases regulate membrane trafficking by interaction with multiple 
effectors, including sorting adaptors, motor linkers, tethering complexes, fusion linkers, protein 
kinases and phosphatases, Rab regulators and more 175. Here, the specific functions of Rab1b 
and Rab11a are described in more detail, because these two small GTPases are host factors 
identified in siRNA screens as candidates with a role in UUKV infection 80. 
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Figure 8: Rab GTPases as molecular switches 
Rab proteins switch between an active GTP-bound and an inactive GDP-bearing state. 1) Intrinsically soluble Rab 
proteins attach to a Rab escort protein (REP) to be prenylated by the Rab geranylgeranyl transferase (RabGGTase). 
2) The prenylated protein is anchored to the membrane, where guanine-nucleotide exchange factors (GEFs) 
activate Rab by replacing guanosine diphosphate (GDP) for guanosine triphosphate (GTP). 3) Activated GTP-
bearing Rab interacts with effectors to regulate membrane trafficking. 4) The intrinsic Rab GTPase activity is 
enhanced by GTPase-activating proteins (GAPs), resulting in GTP hydrolysis to GDP, to discontinue its function. 
GDP associated Rab proteins are recognized and dissociated from the membrane by guanine-nucleotide-
dissociation inhibitors (GDIs). Adapted from 176. 
 
7.5.1 Rab1b 
Rab1b is predominantly present in ER and Golgi apparatus membranes and regulates vesicle 
trafficking between those two organelles. ER to Golgi transport is an important step for the 
export of secretory and plasma membrane proteins for example and is mediated inside coat 
protein complex (COP)-coated vesicles. Upon activation, Rab1b regulates anterograde 
transport of COPII-coated vesicles from ER exit sites (ERES) to the ERGIC 107. The exchange 
of COPII for COPI is suggested to be as well regulated by Rab1b 177. Rab1b indirectly activates 
the COPI-recruiting GTPase Arf1 by activating the Arf1-GEF Golgi-specific brefeldin A 
resistance factor 1 (GBF1) 178–180. COPI vesicles allow anterograde transport to the Golgi as 
well as retrograde transport back to the ER 181. 
A more recently identified function of Rab1b is related to autophagosome formation. Reduced 
Rab1b expression compromises autophagosome formation, indicating that Rab1b is important 
for initial steps of autophagy. In line with these results Kakuta and colleagues report that Rab1b 
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GTPases are associated to Atg9 positive vesicles, a transmembrane protein controlling early 
steps of autophagosome biogenesis 141. While inhibition of Sar1, a small GTPase crucial for 
COPII vesicle formation, blocks autophagosome formation, inhibition of Arf1, a small GTPase 
crucial for COPI vesicle formation, has no effect. These results indicate that early but not late 
steps of the secretory pathway are required for autophagy 109. 
 
7.5.2 Rab11 
The small GTPase Rab11 subfamily comprises three isoforms: Rab11a, Rab11b and Rab25 
(also referred to as Rab11c) among which Rab11a is by far the best studied. Rab11a is 
ubiquitously expressed in a variety of different tissues ranging from brain, lung, heart, liver, 
kidney and spleen to the gastrointestinal tract 182. In contrast to Rab11a, Rab11b expression is 
restricted to the brain, heart and testes 183 and Rab25 is abundant in the gastric tract, kidney and 
lung 184. 
All three isoforms reside in the recycling endosome (RE), and Rab11a also in the trans-Golgi 
network (TGN) (Figure 9) 185–187. Two different cellular exocytic routes are associated with 
these two organelles. The secretory pathway transports newly synthesized proteins from the ER 
via the Golgi apparatus to the plasma membrane. The recycling pathway moves internalized 
cargo via recycling endosomes back to the cell surface 188. Indeed, the three isoforms of Rab11 
control trafficking through recycling endosomes 185–187. Similar functions for Rab11a and 
Rab11b were reported in the recycling of the transferrin receptor from the RE to the plasma 
membrane 185,186,189. Both proteins interact with the exocyst complex to fuse REs with the 
plasma membrane (Figure 9) 190. But also selective regulation of specific recycling pathways 
for all three Rab11 isoforms 187,191 and localization to distinct vesicular compartments were 
reported 192. 
Cellular uptake or a fast recycling from early EEs does not depend on Rab11a. Early (fast) 
recycling is regulated by Rab4 193, while Rab11a regulates recycling from LEs (slow) via the 
RE to the cell membrane 194. Besides its function in the RE, Rab11a also controls constitutive 
and regulated secretory pathways from the TGN to the plasma membrane (Figure 9) 195,196. 
Rab11a moves vesicles primarily along microtubules by interactions with kinesin motor 
proteins, but also along actin filaments by interaction with myosin V 197,198. In addition, Rab11a 
decorates MVBs in human K562 erythroleukemia cells and mediates homotypic MVB-MVB 
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fusion 199 and autophagosome-MVB fusion, resulting in the formation of amphisomes (Figure 
9) 200.  
 
Figure 9: Rab11-regulated processes 
The small GTPase Rab11 is present on recycling endosomes (REs), the trans-Golgi network (TGN) and 
multivesicular bodies (MVBs) to regulate endosomal recycling, secretion, phagophore (PP) formation and 
amphisome formation. AP = autophagosome, EE = early endosome, ER = endoplasmic reticulum, LE = late 
endosome. Adapted from 108. 
 
Other research groups showed that Rab11a- & Rab11b-dependent vesicle transport from REs 
contributes to autophagosome formation and delivers key autophagy proteins, including ULK1 
and Atg16L1 110,201. In line with these results and in addition to the current belief that 
autophagosomes are derived from the ER, Puri and colleagues propose an emergence from 
Rab11a-positive REs 129 (Figure 9). Rab11a-positive membranes serve as a platform for 
phagophore formation. Simultaneous recognition of PI3P and Rab11a allows WIPI2 
recruitment. In turn, WIPI2 binds Atg16L1, thereby giving rise to the site of autophagosome 
formation (Figure 10). 
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Figure 10: Rab11a positive membrane as a compartment for phagophore formation 
1) PI3P and Rab11a-positive membranes may constitute a platform for autophagosome formation by recruiting 
WIPI2. 2) WIPI2 in turn would recruit Atg16L1. 3) Atg16L1 would then form a complex with two other 
autophagy-related proteins. The Atg16L1 complex is an E3-like enzyme, catalyzing LC3 lipidation (LC3-II 
formation). 4) The autophagosome marker LC3-II recruits cargo and elongates the phagophore. Atg2, present in 
the vicinity of the phagophore formation platform, completes autophagosome closure. Adapted from 129. 
 
 
7.6 Relationship between autophagy and endocytosis 
In short, autophagy describes a process for lysosomal degradation of intracellular components. 
Cytoplasmic constituents are engulfed in a double membrane, termed autophagosome and 
fusing with the lysosome to form the autolysosome. During endocytosis, extracellular 
components are internalized at the plasma membrane and trafficked through early endosomes 
to late endosomes and finally fuse with the lysosome (Figure 9). 
Both pathways intersect already at their very initial stage, i.e. the cellular plasma membrane 
serves as membrane donor for endosomes and autophagosomes (note: further membrane 
sources are involved in autophagosome formation. See chapter 7.4.4.3). Clathrin- and dynamin-
dependent formation of Atg16L1 positive vesicles at the plasma membrane is involved in 
phagophore formation 137. Clathrin-mediated endocytosis presents also a possible means to 
deliver membrane and content to EEs 75. 
Autophagy and endocytosis directly intersect by fusion of autophagosomes with endosomes, 
termed amphisome formation. Autophagosome-MVB fusion is proposed to be regulated by 
Rab11a (Figure 9) 200 and VAMP3 105. For maturation, autophagosomes acquire LAMPs and 
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vATPases. These proteins are also found on MVBs, LEs and LYs, indicating that both 
maturation processes are accompanied by acidification. Both pathways involve Rab7, a protein 
for LE maturation and autophagosome-lysosome fusion 75,147. Accumulating evidences support 
the idea that autolysosome formation relies on a functional endocytic pathway because 
disruption of early endosome trafficking or MVB formation leads to an accumulation of 
autophagosomes and amphisomes 202,203.  
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8 Objectives of the study 
The aim of my PhD project is to investigate early phlebovirus-host cell interactions. Genome-
wide siRNA screens previously performed in our lab 80 identified VAMP3 as a host cellular 
factor critical for UUKV late penetration into HeLa cells. VAMP3 is a SNARE protein present 
in recycling endosomes and involved in exocytic processes and autophagy 100,101,104,105. In 
addition to VAMP3 a number of other autophagy-related proteins appeared as potential host 
factors in the siRNA screens, namely WIPI1, FIP200, Rab1b, and Rab11a. This led to our 
hypothesis that autophagy plays a role in the early steps of UUKV infection. 
The knowledge on the interplay between phleboviruses and autophagy is very limited. 
Individual studies on RVFV and SFTSV propose an antiviral role of autophagy in infection 
158,159. To date no study is published, describing the role of autophagy in UUKV infection. To 
test our working hypothesis and whether UUKV relies on the autophagic pathway for infection, 
I examined the role of several autophagy-related proteins as well as that of autophagosome 
maturation in UUKV infection. 
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9 Materials and Methods 
9.1 Materials 
9.1.1 Devices and Instruments 
Device / Instrument Provider 
Bacteria centrifuge Avanti J-20 XP Beckman Coulter, Brea, USA 
Bacteria incubator  Memmert, Schwabach, Germany 
Bacteria shaker Multitron Pro Infors, Bottmingen, Switzerland 
Blotting system (iBlot gel transfer device) Invitrogen, Thermo Fisher Scientific, 
Carlsbad, USA 
Cell culture centrifuge Megafuge 40R Thermo Fisher Scientific, Waltham, USA 
Cell culture incubator C200 Labotect, Göttingen, Germany 
Cell culture wide field microscope Hund, Wetzlar, Germany 
Flow cytometer BD FACSCalibur BD Bioscience, Franklin Lakes, USA 
Flow cytometer BD FACSCelesta BD Bioscience, Franklin Lakes, USA 
Flow cytometer BD FACSVerse BD Bioscience, Franklin Lakes, USA 
Fluorescence plate reader, Typhoon Trio, 
variable mode imager 
GE Healthcare, Chicago, USA 
Freezer -80°C Thermo Fisher Scientific, Waltham, USA 
Fridge 4°C Liebherr, Kirschdorf, Germany 
Laboratory centrifuge 5430R Eppendorf, Hamburg, Germany 
Leica SP5 laser confocal scanning microscope Leica Microsystems, Wetzlar, Germany 
Leica SP8 laser confocal scanning microscope Leica Microsystems, Wetzlar, Germany 
Licor Odyssey CLx Licor, Lincoln, USA 
Malassez counting chamber Brand, Wertheim, Germany 
Nanophotometer NP80 Touch Implen, Munich, Germany 
pH-meter FiveEasy Mettler-Toledo, Columbus, USA 
Precision scale EW220-3NM Kern, Balingen, Germany 
Rocker Polymax 1040 Heidolph, Schwabach, Germany 
Rotor SW 32 Ti Beckman Coulter, Brea, USA 
Rotor SW 60 Ti Beckman Coulter, Brea, USA 
Scale 650-2NM Kern, Balingen, Germany 
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SDS-PAGE chamber (Novex Mini-Cell) Invitrogen, Thermo Fisher Scientific, 
Carlsbad, USA 
Ultracentrifuge L8-60M Beckman Coulter, Brea, USA 
Water bath GFL, Burgwede, Germany 
 
9.1.2 Consumables 
Consumable Provider 
12 mm round cover glasses Marienfeld, Lauda-Königshofen, Germany 
24 well plate, flat bottom, Cellstar Greiner bio-one, Frickenhausen, Germany 
6 well plate, flat bottom, Cellstar Greiner bio-one, Frickenhausen, Germany 
96 well plate, U-bottom, Cellstar Greiner bio-one, Frickenhausen, Germany 
Cell culture flask T125 
(Cell Star, Ref. 660160) 
Greiner bio-one, Frickenhausen, Germany 
Cell culture flask T25 
(Cellstar, Ref. 690160) 
Greiner bio-one, Frickenhausen, Germany 
Cell culture flask T75 
(Cellstar, Ref. 658170) 
Greiner bio-one, Frickenhausen, Germany 
Centrifuge tubes, open top, polyclear SW32 Seton, Petaluma, USA 
Centrifuge tubes, open top, polyclear SW60 Seton, Petaluma, USA 
Cryotube, 2 mL Greiner bio-one, Frickenhausen, Germany 
Microscopy slides Marienfeld, Lauda-Königshofen, Germany 
Needle, 0.4 x 19 mm BD Bioscience, Franklin Lakes, USA 
Precast Protein gels, 10 % Bis-Tris, 
NuPAGE 
Thermo Fisher Scientific, Waltham, USA 
Sterile filter 0.22 µM, bottle top filter Merck, Darmstadt, Germany 
Sterile filter 0.22 µM, Luer Lock for syringe Whatman, Maidstone, United Kingdom 
Sterile filter 0.45 µM, Luer Lock for syringe Whatman, Maidstone, United Kingdom 
Syringe, Luer Lock, 3 mL BD Bioscience, Franklin Lakes, USA 
Transfer stack, PVDF (iBlot) Invitrogen, Thermo Fisher Scientific, 
Carlsbad, USA 
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9.1.3 Commercial kits 
Kit Provider 
CalPhos Mammalian Transfection Kit 
(Ref. 631312) 
Clontech Laboratories, Mountain View, 
USA 
DAB Peroxidase Substrate Kit Vector Laboratories, Burlingame, USA 
DNA Plasmid Plus Midi Kit Qiagen, Hilden, Germany 
 
9.1.4 Chemicals and Reagents 
Chemical / Reagent Provider 
Acetic acid  Merck, Darmstadt, Germany 
Agarose (for LB agar plates) Carl Roth, Karlsruhe, Germany 
Albumin Fraction V, powder (BSA) Carl Roth, Karlsruhe, Germany 
Alexa Fluor 488 NHS Ester (succinimidyl 
ester) 
Thermo Fisher Scientific, Waltham, USA 
Alexa Fluor 568 NHS Ester (succinimidyl 
ester) 
Thermo Fisher Scientific, Waltham, USA 
Alexa Fluor 647 NHS Ester (succinimidyl 
ester) 
Thermo Fisher Scientific, Waltham, USA 
Ammonium chloride (NH4Cl) Sigma-Aldrich, St. Louis, USA 
Ampicillin Carl Roth, Karlsruhe, Germany 
Bafilomycin A1 Sigma-Aldrich, St. Louis, USA 
Blasticidin Invivogen, San Diego, USA 
Bovine Albumin Fraction V (7.5 % solution) 
(BSA) 
Thermo Fisher Scientific, Waltham, USA 
Calcium chloride (CaCl2) Sigma-Aldrich, St. Louis, USA 
Carboxymethyl cellulose (CMC) Sigma-Aldrich, St. Louis, USA 
Citric acid monohydrate Sigma-Aldrich, St. Louis, USA 
Coomassie brilliant blue G-250 Thermo Fisher Scientific, Waltham, USA 
Crystal violet Sigma-Aldrich, St. Louis, USA 
D(+)-Saccharose Carl Roth, Karlsruhe, Germany 
Dimethyl sulfoxide (DMSO) Merck Millipore, Burlington, USA 
Enhanced chemoluminescent substrate (ECL), 
SuperSignal West Pico 
Thermo Scientific, Schwerte, Germany 
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Ethanol Merck, Darmstadt, Germany 
Ethylenediaminetetraacetic acid (EDTA) 0.5 M 
pH8 
Invitrogen, Thermo Fisher Scientific, 
Carlsbad, USA 
Fetal bovine serum (FBS) Thermo Fisher Scientific, Waltham, USA 
Fetal calf serum (FCS) Merck, Darmstadt, Germany 
Formaldehyde solution 37 % 
(used for flow cytometry) 
Merck, Darmstadt, Germany 
Glycerol Labochem international, Einhausen, 
Germany 
Kanamycin Carl Roth, Karlsruhe, Germany 
LB Medium Powder Carl Roth, Karlsruhe, Germany 
Lipofectamine 2000 transfection reagent Invitrogen, Thermo Fisher Scientific, 
Carlsbad, USA 
Lipofectamine RNAiMAX transfection reagent Invitrogen, Thermo Fisher Scientific, 
Carlsbad, USA 
Magnesium chloride (MgCl2) hexahydrate Merck, Darmstadt, Germany 
Methanol VWR International, Radnor, United 
States 
Milk powder, blotting grade Carl Roth, Karlsruhe, Germany 
Mowiol 4-88 Sigma-Aldrich, St. Louis, USA 
N-tosyl-L-phenylalanine chloromethyl ketone 
(TPCK)-treated trypsin 
Sigma-Aldrich, St. Louis, USA 
Paraformaldehyde solution, 16 % w/v, 
methanol free (used for imaging) 
Alfa Aesar, Haverhill, USA 
Penicillin-Streptomycin 100X solution Pan Biotech, Aidenbach, Germany 
Phosphate buffered saline (PBS) Merck, Darmstadt, Germany 
Protease inhibitor cocktail tablets Roche, Basel, Switzerland 
Protein Standard, SeeBlue Plus2 Prestained 
(Ref. LC5925) 
Thermo Fisher Scientific, Waltham, USA 
Puromycin Invivogen, San Diego, USA 
Rapamycin (dissolved in Methanol) Sigma-Aldrich, St. Louis, USA 
Saponin Serva, Heidelberg, Germany 
Sodium azide (NaN3) Merck, Darmstadt, Germany 
Sodium bicarbonate solution 7.5 % Thermo Fisher Scientific, Waltham, USA 
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Sodium chloride (NaCl) Bernd Kraft, Oberhausen, Germany 
Sodium citrate monobasic Sigma-Aldrich, St. Louis, USA 
Tris base Carl Roth, Karlsruhe, Germany 
Triton X-100 Merck, Darmstadt, Germany 
Trypan blue solution 0.4 % Sigma-Aldrich, St. Louis, USA 
Trypsin/EDTA 10X Pan Biotech, Aidenbach, Germany 
Tryptone Sigma-Aldrich, St. Louis, USA 
Tryptose phosphate broth (TPB) Sigma-Aldrich, St. Louis, USA 
Tween 20 Carl Roth, Karlsruhe, Germany 
Ultrapure agarose Thermo Fisher Scientific, Waltham, USA 
Vybrant Dye Cycle Green Thermo Fisher Scientific, Waltham, USA 
Wortmannin (dissolved in Methanol) Merck, Darmstadt, Germany 
Yeast extract Sigma-Aldrich, St. Louis, USA 
 
9.1.5 Buffers and Solutions 
Buffer / Solution Supplements 
Coomassie staining solution Methanol 50 %  
Acetic acid 10 %  
Coomassie brilliant blue 0.25 % (w/v) 
in dH2O 
Crystal violet staining solution Crystal violet 0.25 % (w/v) 
Ethanol 10 % 
Formaldehyde 7.4 % 
in dH2O 
FACS buffer (FB) FCS 2 % 
in PBS 1X 
FACS permeabilization buffer (FPB) FCS 2 % 
EDTA 5 mM 
NaN3 0.02 % (w/v) 
Saponin 0.1 % (w/v) 
in PBS 1X 
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Fixative solution Methanol 40 % 
Acetic acid 10 % 
in dH2O 
LB agar Agarose 13% 
in LB medium 
LB medium Tryptone 1 % 
yeast extract 0.5 % 
NaCl 171 mM 
in H2O 
LDS sample buffer 4X, NuPAGE Thermo Fisher Scientific, Waltham, USA 
Lysis buffer Triton X-100 0.01 % 
Protease inhibitors 
in TNE 1X 
Mowiol mounting medium Glycerol 33 g 
Mowiol 4-88 13 g 
Tris base 66 mL (use 100 mM Tris base 
stock solution, adjusted to pH 8.5) 
ad 100 mL dH2O 
MOPS SDS running buffer 20X, NuPAGE Thermo Fisher Scientific, Waltham, USA 
TBS-Tween (TBST) Tween 20 0.1% 
in TBS 1X 
Tryptose phosphate broth (TPB) 29.5 % (w/v) 
Carboxymethyl cellulose (CMC) Carboxymethyl cellulose 3.2 % (w/v) 
NaCl 0.85 % (w/v) 
autoclaved 
HEPES - NaCl - EDTA (HNE), pH 7.4 
10X stock solution 
HEPES 100 mM 
NaCl 1 M 
EDTA 20 mM 
0.22 µM sterile filtered after pH adjustment 
Tris-buffered saline (TBS), pH 7.6 
10X stock solution 
Tris base 200 mM  
NaCl 1.5 M  
0.22 µM sterile filtered after pH adjustment 
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9.1.6 Media used for cell culture and infection assays 
Medium (Provider) Supplements 
Complete DMEM 
DMEM, high glucose, with GlutaMAX 
(Gibco, Karlsruhe, Germany) 
Ref: 61965-026 
FCS 10 % 
Penicillin 100 units/mL 
Streptomycin 100 µg/mL 
Complete GMEM 
GMEM, high glucose, with L-glutamine 
(Gibco, Karlsruhe, Germany) 
Ref: 11710-035 
TPB 10 % 
FBS 5 % 
Penicillin 100 units/ml 
Streptomycin 100 µg/mL 
Freezing medium FCS (or FBS for BHK-21 cells) 90 %  
DMSO 10 %  
Infection medium (pH 7.0 – 7.4): 
DMEM, high glucose, with GlutaMAX 
(Gibco, Karlsruhe, Germany) 
Ref: 61965-026 
HEPES 20 mM 
BSA 0.2 %  
MgCl2 2 mM 
CaCl2 1 mM 
Opti-MEM, with L-glutamine 
(Gibco, Karlsruhe, Germany) 
Ref: 11058-021 
None 
Overlay solution 
1:1 dilution of solution A and B 
Solution A: Agarose 1.8 % in dH2O 
Solution B: Sodium bicarbonate 0.45 % in 
complete GMEM 
pH 5 buffer  
RPMI with GlutaMAX 
(Gibco, Karlsruhe, Germany) 
Ref: 61870 
BSA 0.2 % 
Citric acid 2.1 mg/ml 
Sodium citrate 5.6 mg/ml 
0.22 µM sterile filtered after pH adjustment 
pH 7 buffer (pH 7): 
RPMI with GlutaMax 
(Gibco, Karlsruhe, Germany) 
Ref: 61870 
BSA 0.2 %  
HEPES 30 mM 
0.22 µM sterile filtered after pH adjustment 
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9.1.7 Plasmids 
Plasmid Description Provider 
pCDNA3-VSV-G Vesicular Stomatitis Indiana virus G-
protein (VSV-G) expression vector for 
lentivirus pseudotyping 
Zennou et al., 2010 204 
P8.71 Packaging vector for lentiviral particle 
production 
Zennou et al., 2010 204 
plKO.1puro Atg3 F1 
plKO.1puro Atg3 F2 
plKO.1puro Bec1 
Transgene vector, encoding shRNA against 
Atg3 or Beclin 1, a puromycin resistance 
and the packaging signal for lentivirus 
particle production 
Dr. Nathan Brady 
(John Hopkins, 
Baltimore, USA) 
pEGFP-Rab5 WT Expression plasmid for eGFP-Rab5a WT Lozach et al., 2010 37 
pEGFP-Rab5 S34N Expression plasmid for eGFP-Rab5a 
dominant negative mutant 
Lozach et al., 2010 37 
pEGFP-Rab11a WT Expression plasmid for eGFP-Rab11a WT Prof. Urs Greber 
(University of Zürich, 
Zürich, Switzerland) 
pEGFP-Rab11a 
S25N 
Expression plasmid for eGFP-Rab11a 
dominant negative mutant 
pEGFP-Rab11a 
Q70L 
Expression plasmid for eGFP-Rab11a 
constitutively active mutant 
pEGFP-LAMP1 Expression plasmid for eGFP-LAMP1 WT Dr. Thomas Heger 
(ETH, Zürich, 
Switzerland) 
 
9.1.8 siRNAs 
siRNA 5’-3’ Sequence Provider 
ATG5_1 GGAUGCAAUUGAAGCUCAU Thermo Fisher Scientific, 
Waltham, USA ATG5_2 GAACCAUACUAUUUGCUUU 
ATG5_3 GCUAUAUCAGGAUGAGAUA 
ATG7_1 GGAACACUGUAUAACACCA 
ATG7_2 CGCUUAACAUUGGAGUUCA 
ATG7_3 GAAGCUCCCAAGGACAUUA 
ATP6V1A CAUGGUCCAUUAUUCGUGA 
BECN1_1 CAGUUACAGAUGGAGCUAA 
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BECN1_2 GCAGUUCAAAGAAGAGGUU 
BECN1_3 CAGAUACUCUUUUAGACCA 
FIP200_1 (RB1CC1) CGAUAGACAGUAGACGAAU 
FIP200_2 (RB1CC1) GCCUAGAACAACUAACGAA 
FIP200_3 (RB1CC1) GUCGUCUCCUAAUCCUAUA 
RAB11A_1 CAACAAUGUGGUUCCUAUU 
RAB11A_2 GAGAUUUACCGCAUUGUUU 
RAB11A_3 GGAGUAGAGUUUGCAACAA 
RAB11B_1 CUAACGUAGAGGAAGCAUU 
RAB11B_2 GCAACGAGUUCAACCUGGA 
RAB1B_1 GCUGAAAUCAAAAAGCGGA 
RAB1B_2 AGAGCGACCUCACCACCAA 
RAB1B_3 GCACCAGCCUUAACCCUCA 
SiSel NC1 (scrambled) No sequence information available 
WIPI1_1 GCACUAUUGCUGCCCAUGA  
WIPI1_2 GAAACUCCCUGAAAACAGU 
WIPI1_3 CCCUCUCAACGAUCCAGAA 
VAMP3.4 CCCAAAUAUGAAGAUAAACUA Qiagen, Hilden, 
Germany 
 
9.1.9 Viruses 
- Uukuniemi virus strain 23 (UUKV) was isolated from Ixodes ricinus ticks 205. The 
strain results from five consecutive plaque purifications in chicken embryo fibroblasts 
followed by passages in BHK-21 cells 35. 
- Influenza A virus (A/Puerto Rico/8/1934(H1N1)) (IAV), was produced with the 
reverse genetics system on MDCK cells and kindly provided by Dr. Susann Kummer, 
group of Prof. Kräusslich, Virology, Heidelberg. 
- Semliki Forest virus (SFV) 37 
- Rift Valley fever virus delta NSs eGFP (RVFV ΔNSs-eGFP) was produced and 
tittered on Vero E6 cells by Nicole Cordes, former group member of Dr. Lozach, 
Virology, Heidelberg 
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9.1.10 Bacteria 
- E. coli DH5α, chemically competent from Gibco, genotype: F− 80dlacZM15 (lacZYA-
argF) U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44 – thi-1 gyrA96 relA1, was 
used for plasmid production. 
 
9.1.11 Mammalian cells 
Cell line Origin 
BHK-21 Received from Roberta Mancini (ETH, Zürich, 
Switzerland) 
HEK 293T Received from ETH, Zürich, Switzerland 
HeLa DC-SIGN 
(referred to as HeLa) 
Lozach et al., 2005 99 
HeLa DC-SIGN BFP-LC3 
(referred to as HeLa BFP-LC3) 
Transduced with the lentivirus system by Dr. Verena 
Lang (formerly group of Prof. Nathan Brady, John 
Hopkins, Baltimore, USA). Sorted with the cell sorter 
by Dr. Monika Langlotz (Flow Cytometry & FACS 
Core Facility (FFCF), Heidelberg, Germany). 
HeLa DC-SIGN shATG3 
(referred to as HeLa shATG3) 
Prepared in this thesis (chapter 9.3.5) 
HeLa DC-SIGN shBECN1 
(referred to as HeLa shBECN1) 
Prepared in this thesis (chapter 9.3.5) 
HeLa 
(referred to as parental HeLa) 
Received from ETH, Zürich, Switzerland 
Huh7 ATG14L KO 
Prepared with the CRISPR/Cas9 genome-editing 
system, kindly provided by Dr. Keisuke Tabata, group 
of Prof. Bartenschlager, Molecular Virology, 
Heidelberg  
Huh7 ATG16L1 KO 
Huh7 ATG3 KO 
Huh7 ATG5 KO 
Huh7 ATG7 KO 
Huh7 ATG9L1 KO 
Huh7 control 
Huh7 FIP200 KO 
 
 
Materials and Methods 
43 
9.1.12 Primary antibodies 
Target protein 
(antibody name) 
Species Dilution Method Provider 
Actin Mouse 
monoclonal 
1:1000 WB Santa Cruz 
(Ref. sc-58679) 
Atg3 Rabbit 
polyclonal 
1:1000 WB Cell Signaling 
(Ref. 3415) 
Atg7 Rabbit 
monoclonal 
1:200 WB Cell Signaling 
(Ref. 8558) 
Beclin 1 Rabbit 
polyclonal 
1:1000 WB Cell Signaling 
(Ref. 3738) 
DC-SIGN / 
CD209 
(conjugated 
FITC) 
Mouse 
monoclonal 
1:50 Flow cytometry R&D Systems 
(Ref. FAB161F) 
IAV-N Mouse 
monoclonal 
1:250 Flow cytometry Merck Millipore 
(Ref. MAB8257) 
Rab11a Rabbit 
polyclonal 
1:1000 
1:50 
WB 
microscopy 
Cell Signaling 
(Ref. 2413) 
Rab1b Mouse 
monoclonal 
1:100 WB Sigma Aldrich 
(Ref. SAB1400720) 
SFV-E2 Mouse 
monoclonal 
1:400 Flow cytometry Prof. Margaret Kielian 
UUKV 
(U2) 
Rabbit 
polyclonal 
1:1000 Focus-forming assay Dr. Pierre-Yves Lozach 
UUKV-N 
(8B11A3) 
Mouse 
monoclonal 
1:400 Flow cytometry Dr. Anna Överby 
α-tubulin Mouse 
monoclonal 
1:1000 WB Sigma Aldrich 
(Ref. T5168) 
β-actin Mouse 
monoclonal 
1:1000 WB Sigma-Aldrich 
(Ref. A2228) 
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9.1.13 Secondary antibodies 
Antibody name Species Dilution Method Provider 
Anti-mouse AF488 Goat  1 : 500 Flow cytometry Thermo Fisher Scientific 
Anti-mouse AF647 Goat 1 : 500 Flow cytometry Thermo Fisher Scientific 
Anti-mouse HRP Goat 1 : 10 000 WB Santa Cruz 
Anti-rabbit AF405 Goat 1 : 500 Microscopy Thermo Fisher Scientific 
Anti-rabbit HRP Goat 1 : 10 000 WB Santa Cruz 
 
 
9.1.14 Image Analysis Programs 
Program Application 
FlowJo V10 Flow cytometer data analysis 
Icy Bioimage analysis 
ImageJ Bioimage analysis  
Odyssey Image Studio Software Protein analysis 
 
9.1.15 Services 
Company / Facility Service 
Flow Cytometry & FACS Core Facility (FFCF), Heidelberg, Germany Cell sorting 
Advanced Biological Screening Facility, Heidelberg, Germany siRNA ordering 
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9.2 Cellular biology methods 
9.2.1 Mammalian cell culture 
All cell lines were cultured at 37°C in a humidified atmosphere (90 % relative humidity) with 
5 % CO2. BHK-21 cells were kept in cell culture flasks in complete GMEM, all other 
mammalian cell lines were kept in cell culture flasks in complete DMEM. Cells were monitored 
with a wide field microscope and split twice a week by a 1:10 to 1:20 dilution according to their 
confluency. For passaging, trypsin/EDTA was added onto PBS-washed cells for 2-5 minutes to 
detach adherent cells. Complete medium was added to inactivate trypsin and to resuspend the 
cells. For long term storage, cells were cryopreserved and kept at -80°C or in liquid nitrogen. 
For cryopreservation the cells were pelleted at 300 x g for 5 minutes and taken up in FBS or 
FCS. 10 % DMSO was added dropwise while swirling the cells in FBS. 1 mL freezing medium 
contained 1-3x106 cells and was frozen in one cryotube. Slow temperature decrease was 
allowed overnight in isopropanol tanks inside a -80°C freezer and cells were then taken out the 
isopropanol tank and kept at -80°C or in liquid nitrogen. 
9.2.2 Cell lysis 
Adherent cells were lysed by adding 200 µL lysis buffer per well of a 24 well plate. After 15 
minutes incubation on ice, the cells were scraped off with a pipet tip and transferred into a 1.5 
mL reaction tube and incubated again 15 minutes on ice. Next, the cell lysate was centrifuged 
for 20 minutes at 12 000 x g at 4°C. Cell lysates were stored at -20°C and further used for SDS-
PAGE and western blot (chapter 9.4.2). 
9.2.3 Heat shock transformation and plasmid preparation 
Chemically competent E. coli DH5α cells were thawed on ice. 20 ng plasmid (chapter 0) was 
added to 50 µL E. coli DH5α cells and gently mixed. After 30 minutes incubation on ice, the 
bacteria were heat-shocked for 30 seconds at 42°C in a water bath and returned onto ice. 250 
µL LB medium were added. Bacteria were incubated for 1 h at 37°C and shaken at 145 rpm. 
100 µL bacterial suspension was then plated onto selective LB-agarose plates. The plates were 
incubated at 37°C overnight. Bacterial colonies were visible after 16 hours incubation. 
To amplify the transformed plasmid, a single colony was picked with a sterile pipet tip, 
inoculated into 50 mL selective LB medium and incubated for 14-16 h at 37°C while shaken at 
145 rpm. The bacterial suspension was pelleted in 50 mL conical tubes by centrifugation at 
5000 x g at 4°C for 10 minutes. The supernatant was discarded, and the plasmids were prepared 
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from the pellet with the DNA Plasmid Plus Midi Kit according to the manufacturer’s 
instructions. The DNA concentration was measured with the nanophotometer. 
9.2.4 Cell transfection with siRNAs and DNA plasmids using Lipofectamine 
siRNAs (listed in chapter 9.1.8) were introduced into the cells by reverse transfection using 
Lipofectamine RNAiMAX transfection reagent according to the manufacturer’s instructions. 
In the case of Huh7 cells DMEM was used for transfection instead of Opti-MEM. The utilized 
siRNA concentrations and incubation times are indicated in the respective figure legends. For 
the endocytic bypass assay (chapter 9.2.5.4) and the drug-addition time course (chapter 9.2.5.5), 
reverse transfection was performed in 24 well plates with 25 000 or 30 000 HeLa cells. For all 
other flow cytometry-based infection assays (chapters 9.2.5.1 - 9.2.5.3), reverse transfection 
was performed in 6 well plates with 200 000 HEK 293T cells, 125 000 HeLa cells, 125 000 
parental HeLa cells or 300 000 Huh7 cells. For imaging-based infection assays, reverse 
transfection was performed in 24 well plates with 12 mm round cover glasses and 20 000 HeLa 
cells. 
Applied transfection conditions for Figure 11: 
siRNA  Experiment 
number 
Concentration [nM] Time [h] 
Applied transfection conditions for infection assay 
ATG5 1 + 2 20 72 
3 + 4 10 48 
ATG7 1 + 2 10 72 
3 + 4 10 48 
5 50 72 
BECN1 1 10 48 
2 50 72 
FIP200 (RB1CC1) 1 – 4 20 72 
RAB1B 1 + 2 20 72 
3 20 48 
RAB11A 1 20 48 
2 + 3 10 72 
WIPI1 1 – 5 20 72 
Applied transfection conditions for SDS-PAGE and WB 
ATG7 1 20 72 
RAB1B 1 20 72 
RAB11A 1 10 48 
 
Lipofectamine 2000 transfection reagent was used according to the manufacturer’s instructions 
to introduce 0.5 µg DNA plasmids (listed in chapter 0) for 20-24 h. For flow cytometry-based 
infection assays (chapter 9.2.5.1), plasmid transfection was performed in 24 well plates, and 50 
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000 HeLa cells were seeded 18-22 h before transfection. For imaging-based infection assays, 
70 000 HeLa cells were seeded 18-22 h before transfection onto 12 mm round cover glasses 
(chapter 9.2.7.2). 
9.2.5 Flow cytometry-based infection assays 
Infections assays addressing different steps of the viral life cycle are described in the following 
subchapters. 
9.2.5.1 Infection assays 
Cells were detached with PBS/EDTA 0.5 mM for 5-7 min, transferred into a 15 mL conical 
reaction tube and washed in 10 mL complete DMEM to remove the EDTA. Cells were pelleted 
at 300 x g for 5 minutes and resuspended in warm infection medium. For infection with IAV, 
the infection medium was supplemented with 1 µg/mL TPCK-treated trypsin to cleave the 
surface exposed hemagglutinin and thereby allow IAV infection. 200 000 cells per sample were 
seeded into a 96 well plate with U-bottoms. Cells were again pelleted and infected in suspension 
with 100 µL warm infection medium containing the viral particles. The utilized viral particles 
and MOIs are indicated in the figure legends. 1 hpi the inoculum was removed and replaced by 
200 µL warm complete DMEM. After additional 5 h or 7 h incubation (specified in the figure 
legends) at standard conditions, the cells were fixed and immunostained to determine infectivity 
by flow cytometry (specified in section 9.2.6). 
Plasmid-transfected HeLa cells (chapter 9.2.4) were directly infected in the 24 well plate. The 
number of cells per well was determined by detaching cells from one well (distinct for counting) 
with trypsin/EDTA. A final volume of 300 µL viral particles diluted in warm infection medium 
was added onto the adherent cells for infection. 1 hpi the inoculum was removed and replaced 
by 500 µL warm complete DMEM. After additional 7 h incubation, the cells were fixed and 
immunostained to determine infectivity by flow cytometry (specified in section 9.2.6). 
9.2.5.2 Binding assay with Alexa Flour-labeled viral particles 
Cells were detached with PBS/EDTA 0.5 mM for 5-7 min, transferred into a 15 mL conical 
reaction tube and washed in 10 mL complete DMEM to remove the EDTA. Cells were pelleted 
at 300 x g for 5 minutes and resuspended in cold infection medium. 200 000 cells per well 
seeded into a 96 well plate with U-bottoms. To assure, that endocytic processes are stopped, 
the cells were kept on ice for 10 min. Cells were then pelleted in a precooled centrifuge at 300 
x g for 5 minutes and resuspended in 100 µL cold infection medium with UUKV-AF488 or 
UUKV-AF647 particles . The MOIs are indicated in the figure legends. After binding on ice 
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for 90 min, the cells were washed twice with cold PBS and directly measured for surface 
fluorescence with the flow cytometer (specified in section 9.2.6).  
9.2.5.3 Internalization assay using trypan blue 
UUKV-AF488 was bound to cells on ice in two separate 96 well plates as described in chapter 
9.2.5.2. Cells in the first plate were washed with precooled infection medium to remove 
unbound viral particles and kept on ice until the second 96 well plate was ready. Cells in the 
second 96 well plate were washed with warm infection medium and incubated for 10 minutes 
in a 37°C warm water bath, followed by additional 30 minutes in the incubator. Both plates 
were then washed once with precooled PBS and directly measured with the FACSCelesta. To 
differentiate between plasma membrane-bound and internalized UUKV-AF488 particles, 0.01 
% trypan blue was added to each sample and measured a second time. Data were analyzed with 
the software FlowJo V10. 
9.2.5.4 Plasma membrane-virus fusion assay (endocytic bypass assay) 
130 000 Huh7 ATG7 KO cells or Huh7 control cells were seeded into a 24 well plate 18-22 h 
before infection. HeLa cells transfected with siRNAs (chapter 9.2.4) were used for the 
endocytic bypass assay. The number of cells per well was determined by detaching cells from 
the counting well with trypsin/EDTA and counting them in the Malassez counting chamber. 
The adherent cells were washed once with infection medium. To assure, that endocytic 
processes have stopped, the cells were kept on ice for 10 min. A final volume of 300 µL cold 
infection medium with viral particles was added to the adherent cells. The respective MOIs are 
indicated in the figure legends. After virus particle binding on ice for 1 h, the inoculum was 
removed and 300 µL warm pH5 buffer or 300 µL warm pH7 buffer were added to the cells. 
The 24 well plates with HeLa cells or Huh7 cells were quickly transferred to a 37°C water bath 
for 90 seconds or 60 seconds, respectively. After the incubation period, the pH5 buffer or pH7 
buffer were quickly removed and 1 mL complete DMEM + 20 mM HEPES ± 100 mM 
ammonium chloride (NH4Cl) were added to the cells. Cells were incubated for 6 h (HeLa cells) 
or 8 h (Huh7 cells) in the incubator. The cells were then fixed and immunostained. The 
infectivity was determined by flow cytometry (specified in section 9.2.6). 
9.2.5.5 Drug-addition time course 
HeLa cells transfected with siRNAs (chapter 9.2.4) were used for the drug-addition time course. 
The number of cells per well was determined by detaching cells from the counting well with 
trypsin/EDTA and counting them in the Malassez counting chamber. The adherent cells were 
washed once with infection medium. To assure, that endocytic processes have stopped, the cells 
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were kept on ice for 10 min. Viral particles in 300 µL cold infection medium were added to the 
adherent cells. The respective MOIs are indicated in the figure legends. After virus particle 
binding on ice for 1 h, the inoculum was removed and 500 µL warm complete DMEM was 
added to each well. A rapid temperature shift was guaranteed by letting the 24 well plate float 
in a 37°C warm water bath for 10 minutes, followed by incubation in the incubator. The 
complete DMEM was replaced by complete DMEM with 50 mM NH4Cl at different time points 
(0 / 5 / 10 / 20 / 40 / 80 minutes after the temperature shift to 37°C). Control samples were 
incubated without addition of NH4Cl. HeLa cells were in total incubated 6 h and subsequently 
fixed and immunostained. Infectivity was measured by flow cytometry (specified in section 
9.2.6). 
9.2.6 Cell fixation and immunostaining for flow cytometry 
To assess infectivity, cells were washed twice with PBS, detached with 100 µL trypsin/EDTA 
and transferred into a 96 well plate with U-bottoms. Trypsin was inactivated by adding 100 µL 
complete medium. Cells were again washed with PBS and fixed in 100 µL PBS/formaldehyde 
3.7 % for 20 minutes at RT. After another PBS washing step, cells were permeabilized in 200 
µL FACS permeabilization buffer (FPB) for 5 min. The cells were pelleted by centrifugation at 
300 x g and resuspended in 100 µL diluted primary antibodies. The anti-UUKV-N antibody 
8B11A3 or the anti-SFV-E2 antibody (both diluted 1:400 in FPB) were added to the cells and 
incubated 1 h at RT. Or the anti-IAV-N antibody (diluted 1:250 in FPB) was added to the cells 
and incubated on ice for 1 h. After a washing step with 200 µL FPB, the cells were resuspended 
in 200 µL diluted secondary antibodies anti-mouse AF647 or anti-mouse AF488 (1:500 in FPB) 
and incubated for 1 h at RT or on ice (for IAV infected samples). Cells were then washed twice 
with PBS and kept on ice until measurement with the flow cytometer. Data were analyzed with 
the software FlowJo V10. 
To assess DC-SIGN expression on the cell surface, cells were washed twice with PBS, detached 
with 100 µL trypsin/EDTA and transferred into a 96 well plate with U-bottoms. Trypsin was 
inactivated by adding 100 µL complete medium. Cells were washed with cold FACS buffer, 
and stained in 100 µL anti-DC-SIGN antibody (diluted 1:50 in FACS buffer) for 1 h at 4°C in 
the dark. Cells were then washed twice with PBS and kept on ice until measurement with the 
flow cytometer. Data were analyzed with the software FlowJo V10. 
9.2.7 Imaging-based assays 
Imaging-based assays to assess autophagosome formation and UUKV localization to LC3- or 
Rab11a-decorated vesicles, are described in the following subchapters. 
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9.2.7.1 Autophagy activation in HeLa BFP-LC3 C2 cells 
50 000 HeLa or HeLa BFP-LC3 C2 cells were seeded on 12 mm round cover glasses in a 24 
well plate 14-18 h before drug addition. The cells were washed once with complete DMEM and 
then exposed to 1 mL complete DMEM supplemented with 100 nM bafilomycin A1, 1 µM 
rapamycin or 100 nM wortmannin for 4 h. The cells were washed with PBS and fixed with 150 
µL PBS/methanol free paraformaldehyde 4 % for 20 minutes at RT. After a washing step with 
PBS, the cells were incubated with 100 nM Vybrant Dye Cycle Green (nuclear stain) for 30 
minutes in the incubator. After two additional washing steps with PBS, the 12 mm round cover 
glasses were mounted in 8 µL mowiol mounting medium on a microscopy slide and dried over 
night at 4°C. Images were acquired with the Leica SP5 Laser Confocal Scanning Microscope 
(chapter 9.2.8). 
9.2.7.2 Colocalization assay for UUKV-AF568 with eGFP-Rab11a 
Plasmid-transfected HeLa cells grown on 12 mm round cover glasses in a 24 well plate (chapter 
9.2.4) were used for this colocalization assay. The number of cells per well was determined by 
detaching cells from the distinct well for cell counting with trypsin/EDTA and counting them 
in the Malassez counting chamber. The adherent cells were washed once with infection 
medium. To assure, that endocytic processes have stopped, the cells were kept on ice for 10 
minutes. A final volume of 300 µL cold infection medium with UUKV-AF568 particles (MOI 
0.5) was added to the adherent cells. After binding on ice for 1 h, the inoculum was replaced 
by 500 µL warm complete DMEM. The temperature was rapidly shifted by letting the 24 well 
plates float in the 37°C water bath for the first 10 minutes, followed by incubation in the 
incubator. After the indicated incubation period (0 / 5 / 10 / 15 / 20 / 30 minutes after the 
temperature shift to 37°C), cells were quickly washed with cold PBS and fixed with 150 µL 
PBS/methanol free paraformaldehyde 4 % for 20 minutes in the incubator. After two additional 
washing steps with PBS, the 12 mm round cover glasses were mounted in 8 µL mowiol 
mounting medium on a microscopy slide and dried over night at 4°C. Images were acquired 
with the Leica SP8 Laser Confocal Scanning Microscope (chapter 9.2.8). 
9.2.7.3 Colocalization assay for UUKV-AF568 with BFP-LC3 
50 000 HeLa BFP-LC3 C2 cells were seeded on 12 mm round cover glasses in a 24 well plate 
14-18 h before infection. UUKV-AF568 was bound to HeLa BFP-LC3 C2 cells at an MOI of 
2 and internalization was allowed as described in chapter 9.2.7.2. Fixation, nuclei staining and 
acquisition was performed as described in chapter 9.2.7.1. 
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9.2.8 Confocal fluorescence microscopy 
Multichannel 2D images or 3D stacks were acquired with a confocal laser scanning microscope 
(Leica SP5 or Leica SP8) using a 63X oil immersion objective. Images were recorded with an 
excitation wavelength of 405, 488, 561 and/or 640 nm and stacks had a z-spacing of 300 nm. 
 
9.3 Virology methods 
9.3.1 Production of UUKV particles & SFV particles 
UUKV particles and SFV particles were produced in BHK-21 cells. 14-18 h before infection, 
12x106 BHK-21 cells were seeded in 35 mL complete GMEM into T175 cell culture flasks and 
incubated overnight. Cells were washed once with warm complete GMEM without FBS 
(GMEM with 10 % TPB, Penicillin 100 units/ml, Streptomycin 100 µg/mL). 5 µL UUKV 
particle preparation (unpurified cell culture supernatant of infected cells) was added in 15 mL 
warm complete GMEM without FBS and added to the BHK-21 cells in the T175 cell culture 
flask. The desired MOI was around 0.1. Analogously, 1 µL SFV was added to the cells for SFV 
production. For 1 h incubation in the incubator, the cell culture flasks were carefully swirled 
every 15-20 min. The inoculum was discarded and replaced by 35 mL warm complete GMEM 
without FBS. Virus particles in the supernatant were harvested when a cytopathogenic effect 
was visible in the widefield microscope, usually 48-72 hpi. The supernatant was cleared by 
centrifugation at 1500 x g and 4°C in 50 mL conical reaction tubes and subsequently 
semipurified through a sucrose cushion (chapter 9.3.2). 
9.3.2 UUKV & SFV semipurification 
The supernatant was transferred into SW32 ultracentrifugation tubes. The supernatant from the 
UUKV particle production was underlayed with 2.5 mL HNE/sucrose 25 % (w/v, 0.22 µM 
sterile filtered). The supernatant from the SFV particle production was underlayed with 2.5 mL 
HNE/sucrose 20 % (w/v, 0.22 µM sterile filtered). The samples were centrifuged at 100 000 x 
g at 8°C for 2 h. The supernatant was decanted. 300 µL HNE 1X was added as a resuspension 
buffer to the virus particle pellets and incubated on ice. After 1-2 h the pellets were resuspended 
by up- and down pipetting and pooled. The viral particle preparation was cleared by 
centrifugation at 3000 x g and 4°C for 15 min. The supernatant containing the viral particles 
was then aliquoted and stored at -80°C. 
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9.3.3 UUKV titration by focus-forming assay 
To determine the titer of semipurified (chapter 9.3.2) or labeled (chapter 9.3.5) UUKV particle 
preparation, a focus-forming assay was performed in BHK-21 cells. 100 000 BHK-21 cells per 
well were seeded in complete GMEM in a 24 well plate. 14-18 hours after seeding, a ten-fold 
serial dilution of viral particles was freshly prepared in complete GMEM without FBS. The 
BHK-21 cells were washed with complete GMEM without FBS. Next, 200 µL complete 
GMEM without FBS and 200 µL virus preparation dilution was added to the cells. After 1 h 
incubation, 400 µL CMC with complete GMEM (1:1 dilution) was added to the cells. After 72 
h incubation the virus preparation titers were recorded as follows. The cells were carefully 
washed with complete GMEM without FBS and once with PBS. Next, the cells were fixed with 
PBS/formaldehyde 3.7 % for 20 minutes at RT. The BHK-21 cells were then washed with FPB 
and 300 µL U2 primary antibody (diluted 1:1000 in FPB) was added. After 1 h incubation at 
RT, the cells were again washed with FPB and incubated with 300 µL anti-rabbit HRP 
secondary antibody (diluted 1:200 in FPB) for 1 h at RT. After another washing step with FPB, 
the cells were stained with DAB peroxidase substrate kit according to the manufacturer’s 
instructions and the foci were counted. 
9.3.4 SFV titration by plaque assay 
To determine the titer of semipurified SFV particle solution (chapter 9.3.2), a plaque assay was 
performed in BHK-21 cells. 100 000 BHK-21 cells per well were seeded in complete GMEM 
in a 24 well plate. 14-18 h after seeding, ten-fold serial dilution of viral particles was freshly 
prepared in complete GMEM without FBS. The BHK-21 cells were washed with complete 
GMEM without FBS. Next, 200 µL complete GMEM without FBS and 200 µL virus 
preparation dilution was added to the cells. After 1 h incubation, the inoculum was replaced by 
warm overlay medium (1.8 % agarose and complete GMEM with 0.45 % sodium bicarbonate, 
1:1 diluted). After 1 h incubation, the agarose was solid and the plates were inverted. After 
another 47 h of incubation, the agarose pads were removed carefully. Next, 300 µL crystal 
violet staining solution were added and the plate was incubated for 20 minutes at RT. After 
careful washing of the cells under slow-flowing water, plaques were counted. 
9.3.5 UUKV labeling and purification 
To purify viral particles immediately after the labeling, a linear sucrose gradient, ranging from 
15 to 60 % sucrose (w/v), was prepared in advance. Sucrose solutions containing 15 %, 30 %, 
45 % or 60 % sucrose (w/v) were prepared in HNE 1X. The different sucrose solutions were 
layered on top of each other, starting with of the highest sucrose concentration and ending with 
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the lowest sucrose concentration. 900 µL sucrose solution were pipetted into a SW60 
ultracentrifugation tube and frozen, before 900 µL the next sucrose solution were added. The 
sucrose gradients were kept frozen and thawed overnight at 4°C before use. 
Proteins on the surface of semipurified UUKV particles (chapter 9.3.2) were nonspecifically 
labeled with an Alexa Fluor NHS Ester, which reacts with primary amines. A semipurified 
UUKV particle preparation containing minimum 150 µg UUKV glycoproteins GN & GC per 
mL particle preparation (the glycoprotein concentration was quantified by SDS-PAGE and 
coomassie staining, see chapter 9.4.1), was required for efficient labeling and subsequent 
particle purification. The molar ratio of GN & GC to dye was 1 to 2.5. The required amount of 
Alexa Fluor NHS Ester was freshly dissolved in 50 µL HNE 1X and then added to the particle 
preparation. After 2 h incubation on a rocker in the dark at RT, the virus particle solution was 
layered on top of a linear sucrose gradient. Next, ultracentrifugation was performed for 90 
minutes at 100 000 x g at 4°C. A milky band at a density corresponding to 45 % sucrose was 
extracted with a syringe attached to a needle and further analyzed to assess infectivity by foci-
forming assay (chapter 9.3.3). 
9.3.6 Generation of HeLa cells stably expressing shRNA against Atg3 or Beclin 1 by 
lentivirus transduction 
Lentiviruses were produced on HEK 293T cells. For this, HEK 293T cells were transfected 
with three plasmids: P8.71 (packaging vector), pCDNA3-VSV-G (pseudotype vector) and 
plKO.1puro Atg3 F1 or plKO.1puro Atg3 F2 or plKO.1puro Bec1 (transgene vector). 
Transfection was performed with the CalPhos Mammalian Transfection kit according to the 
manufacturer’s instructions. 24 h and 48 h after the transfection, the medium was replaced by 
fresh complete GMEM. 72 h after the transfection, the supernatant was cleared by 
centrifugation for 5 minutes at 500 x g and 0.45 µM sterile filtered. Lentivirus particle 
preparations were then stored at -80°C. 
These lentivirus particles were used to generate cell lines stably expressing shRNA against Atg3 
or Beclin 1. For this, 125 000 HeLa cells per well were seeded in a 6 well plate and incubated 
overnight. After 14-18 h, the cell culture supernatant was replaced by 1.15 mL lentivirus 
particle containing cell supernatant. 6 hpi and 24 hpi the supernatant was again replaced by 1.15 
mL lentivirus particle containing cell supernatant. 32 hpi lentiviral particles were replaced by 
complete DMEM. When the cells were confluent, they were transferred from the 6 well plate 
to a T25 cell culture flask and selected on complete DMEM supplemented with 5 µg/mL 
puromycin. 
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9.4 Biochemistry methods 
9.4.1 Viral protein analysis by SDS-PAGE & coomassie staining 
To quantify UUKV glycoprotein GN & GC concentrations, different volumes of viral particle 
preparations (5 / 10 / 15 µL) were incubated with LDS sample buffer. The particle samples, and 
2 µL protein ladder were loaded on a precast 10 % Bis-Tris protein gel. For normalization, 
known concentrations of BSA (62.5 / 125 / 250 / 500 / 1000 ng) in LDS sample buffer were 
also loaded onto the gel. Electrophoresis was performed under nonreducing conditions in 
MOPS SDS running buffer at 125 V for 1 h 30 min. The gel was incubated in fixative solution 
for 1 h rocking and then stained in coomassie staining solution for 2 h rocking. Destaining of 
the gel was achieved by multiple washing steps in washing solution while rocking. The gel was 
then imaged with the Licor Odyssey scanner. The Odyssey Image Studio Software or ImageJ 
were used for quantitative analysis of band signal intensities. An example for the calculation of 
UUKV glycoprotein concentrations can be found in our review 206. 
To assess which proteins are fluorescently labeled with the Alexa Fluor NHS Ester, protein gels 
with the fluorescently labeled viral particles were scanned on the fluorescence plate reader 
before fixation. 
9.4.2 Cellular protein analysis by SDS-PAGE & Western blot 
To assess cellular protein expression, cell lysates (chapter 9.2.2) in LDS sample buffer were 
denatured for 5 minutes at 95°C and loaded on a precast 10 % Bis-Tris protein gel. 
Electrophoresis was performed under nonreducing conditions in MOPS SDS running buffer at 
125 V for 1 h 30 min. Subsequently, the proteins were transferred to a Polyvinylidene difluoride 
(PVDF) membrane with a dry blotting system (iBlot). Membranes were blocked in TBS-Tween 
(TBST)/milk 5 % for 1 h at RT on the rocker. Primary antibodies were diluted as indicated in 
chapter 9.1.12 in TBST/milk 5% or TBST/BSA 5% according to the provider’s 
recommendations and incubated over night at 4°C. After three 10 minutes washing steps in 
TBST on the rocker at RT, the membranes were incubated with HRP-conjugated secondary 
antibodies (chapter 9.1.13), diluted in TBST/milk 5 %. Again, three washing steps were 
performed for 10 minutes with TBST on the rocker. Bound secondary antibodies were detected 
by exposure to an enhanced chemiluminescent (ECL) HRP substrate and developed on a foto 
film and digitalized using a scanner. The band and intensities were determined with ImageJ. 
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9.5 Image analysis 
9.5.1 LC3-puncta quantification with ImageJ 
To determine the number of BFP-LC3 puncta per cell, 3D stacks were inverted and minimal 
projected. The noise was reduced with the Gaussian Blur filter. Puncta were selected by 
applying a threshold and the Watershed algorithm was used to separate overlapping objects. 
Next, cells were selected one after another to count puncta with the “Analyze particles” plugin. 
9.5.2 Colocalization analysis with Icy 
Colocalization was determined with the bioimage analysis software Icy 207. The spot detector 
was used to detect viral particles and define their location as a region of interest (ROI). The 
ROI statistics function was then used to obtain the average pixel intensity of other markers 
(eGFP-LAMP1 or BFP-LC3) within these ROIs. A threshold was then applied to define viral 
particle ROIs that colocalize with eGFP-LAMP1 or BFP-LC3. 
9.6 Statistical analysis 
Data analysis was performed using GraphPad Prism software. The standard deviation (SD) was 
plotted and statistical significance was assessed with a two-tailed unpaired Student´s t test. 
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10 Results 
10.1 Autophagy-related proteins in UUKV infection 
The first part of my PhD thesis I focused on the role of autophagy-related proteins in UUKV 
infection. Therefore, we specifically reduced the expression of autophagy-related proteins or 
overexpressed mutants and assessed the effect on UUKV-N protein expression. We selected 
the four autophagy-related proteins appearing as potential host factors in our siRNA screens, 
namely WIPI1, FIP200, Rab1b and Rab11a 80 as well as further key autophagy proteins 
involved in different steps of the macroautophagic pathway. This included FIP200 (part of the 
initiation complex), Beclin 1 and Atg14L (nucleation complex), Atg9L1 and WIPI1 
(phagophore formation), Atg3, Atg5, Atg7 and Atg16L1 (autophagosome elongation) 208 
(Figure 7). We also tested the small GTPases Rab1b and Rab11a because the first is involved 
in the autophagosome formation 109 and the second forms a platform for autophagosome 
assembly 129. 
10.1.1 UUKV infection upon silencing autophagy-related proteins 
To assess the effect of autophagy-related proteins on UUKV infection, siRNA- or shRNA-
mediated silencing was performed in the human cell line HeLa. The cells used in this approach 
expressed the UUKV receptor DC-SIGN, the same line utilized for the siRNA screens from 
which we obtained our autophagy-related host cellular candidates 80. After 6 h infection, newly 
synthetized UUKV nucleoprotein (UUKV-N) was immunostained, detected by flow cytometry 
and positive cells were quantified. An infection rate of 20-40 % was targeted to enable the 
detection of infection decrease but also a potential increase due to silencing of the respective 
proteins. Data were normalized to a scrambled siRNA control. Positive control siRNAs against 
VAMP3, as known host factors involved in UUKV late penetration 80, or against the vacuolar 
proton pump (siATP6V1A), were used. The late penetrating UUKV requires this proton pump 
to maintain a low pH in endosomal compartments for fusion. 
Silencing of Atg7 and Rab11a, each with three nonoverlapping siRNAs, significantly reduced 
UUKV infection by around 50 % (Figure 11a). To assess silencing efficiency, cell lysates were 
analyzed by SDS-PAGE and WB for Atg7, Rab1b, and Rab11a. After immunostaining a 
decreased Atg7 and Rab11a expression was detected as a result of specific siRNA transfection 
(Figure 11c). Reduced protein expression in combination with a decreased infection level 
supported a possible role of Atg7 and Rab11a in UUKV infection. Silencing of Rab1b with 
three nonoverlapping siRNAs reduced UUKV-N protein expression to 69 %, 61 % and 29 % 
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(Figure 11a) while Rab1b expression was clearly decreased (Figure 11c), indicating also a 
potential role of Rab1b in UUKV infection. 
A significant but weaker reduction in UUKV-N protein replication, amounting 42 %, 13 % and 
30 %, was measured for siRNAs targeting ATG5 (Figure 11b). For FIP200 none of the tested 
siRNAs modified the infection level. For BECN1 and WIPI1 only 1 out of 3 siRNA reduced 
infection by 50 % while the other two nonoverlapping siRNAs had no effect (Figure 11a). As 
in all four experiments positive control siRNAs targeting vATPase (siATP6V1A) or VAMP3 
significantly reduced UUKV infection, siRNAs were successfully delivered into HeLa cells. 
But assessment of siWIPI1, siATG5, siBECN1 and siFIP200 silencing efficiency would be a 
prerequisite to conclude on the protein’s role in UUKV infection. 
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Figure 11: Atg7, Rab1b and Rab11a were involved in UUKV infection in HeLa cells 
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(a-b) HeLa cells were transfected with siRNAs (transfection conditions are specified in chapter 9.2.4) and exposed 
to UUKV at a MOI of 0.125 for 6 h. After fixation and permeabilization, infected cells were immunostained for 
UUKV-N and analyzed by flow cytometry. Data were normalized to scrambled control and represent means ± 
standard deviation (SD), n = 2-5, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for 
nonsignificant. (c) HeLa cells were transfected siRNAs (transfection conditions are specified in chapter 9.2.4), 
lysed and analyzed by SDS-PAGE and Western Blot (WB). Band intensity is indicated below the blots. 
To further assess the effect of autophagy-related proteins on UUKV infection, a shRNA-based 
approach was performed. Lentivirus transduction was used to express shRNAs against the two 
key autophagy proteins Atg3 and Beclin 1 in HeLa cells and silencing was assessed with 
immunostaining by WB (Figure 12a). shRNA targeting ATG3 did not significantly modify 
UUKV-N protein expression (Figure 12b) while Atg3 expression was clearly reduced (Figure 
12a). Despite efficient silencing mediated by the shRNA targeting BECN1 (Figure 12a), a 
weak but significant reduction in infected cells was detected upon UUKV infection (Figure 
12b). Together these results suggest no or only a minor role for Atg3 and Beclin 1 respectively 
in UUKV infection. 
 
 
Figure 12: Atg3 and Beclin 1 play a minor role in UUKV infection 
(a) HeLa cells were transduced with lentiviruses to stably express shRNA, lysed and analyzed by SDS-PAGE and 
WB. Band intensity is indicated above the blots. (b) HeLa cells expressing shRNAs were exposed to UUKV at a 
MOI of 0.125 for 6 h. After fixation and permeabilization, infected cells were immunostained for UUKV-N and 
analyzed by flow cytometry. Data were normalized to the scrambled shRNA control and represent means ± SD, n 
= 3 for shATG3, n = 2 for shBECN1, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for 
nonsignificant. 
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10.1.2 Rab11a is involved in UUKV infection 
To complement siRNA-based infection assays, suggesting an involvement of Rab11a in UUKV 
infection, infection was additionally assessed in the presence of dominant negative or 
constitutively active mutants of Rab11a. To this end the GTP binding-defective Rab11a S25N 
mutant (dominant negative mutant), the GTPase-deficient Rab11a Q70L mutant (constitutively 
active mutant) and Rab11a WT (control), all tagged with the eGFP, were used. Additionally, 
the known UUKV entry factor Rab5 WT (control) and the GTP binding-defective Rab5 S34N 
mutant (dominant negative mutant), also tagged with eGFP, were expressed. Transfection of 
HeLa cells with eGFP-Rab11a WT/S25N/Q70L or eGFP-Rab5 WT/S34N expression plasmids 
allowed selection of efficiently transfected cells based on high eGFP expression. In accordance 
with previous findings in A549 and BSC40 cells 37, which do not express DC-SIGN, UUKV-
N protein expression in HeLa cells was also significantly reduced in the presence of Rab5 S34N 
in comparison to Rab5 WT expression (Figure 13). While expression of eGFP-Rab11a Q70L 
had no effect on infection, eGFP-Rab11a S25N significantly reduced the percentage of infected 
cells (Figure 13). Together these results indicate that Rab11a contributes to UUKV infection. 
 
 
Figure 13: Rab11a was involved in UUKV infection in HeLa cells 
HeLa cells were transfected with different expression plasmids coding for eGFP-Rab5 WT/S34N or eGFP-Rab11a 
WT/Q70L/S25N for 24 h and exposed to UUKV at a MOI of 1 for 8 h. After fixation and permeabilization, infected 
cells were immunostained for UUKV-N and analyzed by flow cytometry. Infection was assessed in cells 
expressing a high level of eGFP. Data were normalized to Rab5 WT or Rab11a WT and represent means ± SD, n 
= 3, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for nonsignificant. 
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10.1.3 UUKV infection in Huh7 cells knocked out for key autophagy proteins 
A human hepatocellular carcinoma cell line, Huh7, was chosen to determine, whether the role 
of autophagy-associated proteins in UUKV infection was cell specific. In addition, 
investigations were extended to additional autophagy factors. Huh7 cells are known to be 
sensitive to UUKV infection 37. Knockout mutants were generated with the CRISPR/Cas9 
genome-editing system. Efficient knockout was proven with immunostaining by WB (data not 
shown from our collaborator). In a flow cytometry-based infection assay UUKV-N was 
quantified 8 hours post infection (hpi), as described above (chapter 10.1.1). In accordance with 
our results from siRNA- and shRNA-mediated silencing approaches (Figure 11b, Figure 12b), 
FIP200 or ATG3 knock out had no effect on infection (Figure 14a). Likewise, knockout of 
ATG5, ATG9L1, ATG14L and ATG16L1 did not impact UUKV infection (Figure 14a). Solely 
the knockout of ATG7 significantly reduced UUKV-N expression (Figure 14a) and efficient 
knockout of ATG7 was confirmed with immunostaining by WB (Figure 14b). In line with 
infection assays in HeLa cells (Figure 11a), these data from Huh7 cells supported a role of 
Atg7 in UUKV infection. 
 
 
Figure 14: Atg7 was involved in UUKV infection in Huh7 cells 
(a) Huh7 knockout (KO) cells were exposed to UUKV at a MOI of 0.5 for 8 h. After fixation and permeabilization, 
infected cells were immunostained for UUKV-N and analyzed by flow cytometry. Data were normalized to control 
and represent means ± SD, n = 3, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for 
nonsignificant (b) Huh7 ATG7 KO cells were lysed and analyzed by SDS-PAGE and WB. 
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Altogether these results show that only a subset of assessed autophagy-related proteins were 
involved in UUKV infection. The strongest effects on UUKV-N protein expression arose from 
Atg7 and Rab11a. In the second part of the thesis I therefore focused on the characterization of 
Atg7 and Rab11a functions in UUKV infection and examined during which step of infection 
these two proteins played a role. 
 
10.2 Production of fluorescently labeled UUKV particles to study early virus-
host cell interactions 
Fluorescently labeled viral particles are a useful tool to study UUKV binding to the host cell 
membrane and internalization by flow cytometry or to visualize viral particles by fluorescence 
microscopy to study intracellular trafficking. Envelope proteins of viral particles can be labeled 
nonspecifically with amine-reactive dyes coupled to various fluorophores. Here we used Alexa 
Fluor succinimidyl ester dyes that covalently bind free amine groups in the UUKV envelope 
glycoproteins GN and GC (Figure 16a). 
In the labeling procedure, Alexa Fluor fluorescent dyes were added to the viral particle 
preparation in a defined molar ratio of dye to viral envelope glycoproteins. Hence, UUKV 
envelope glycoproteins GN and GC were semiquantified on a SDS-PAGE gel stained with 
coomassie blue to assess the molarity in the virus stock. The details of this procedure are 
explained in Figure 15. 
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Figure 15: Semiquantification of UUKV GN and GC 
(a) UUKV particles, semipurified through a 25 % sucrose cushion, and BSA standards were analyzed under 
nonreducing conditions on SDS-PAGE and then by coomassie staining. The mean pixel intensity of each band 
was measured within the same defined square by using the software ImageJ. An empty well was used to define 
the background value (BG) and subtracted from all other values. (b) BSA standards were blotted to correlate the 
relative units (RU) with a protein quantity. An equation defining the linear trend line (y=24x) was obtained. (c) 
UUKV glycoproteins were normalized against BSA. To this end the BG was subtracted from the values obtained 
in (a) (RU-BG). Next, the linear trend line obtained in (b) enabled quantification of GN and GC. To calculate the 
molarity, we considered GN and GC as one protein with a molecular weight of 63 400 Da i.e. (0.194 g/L) / (63 400 
g/mol) = 3.1 x 10-6 mol/L. The concentration (w/v) and molarity of GN and GC are indicated in the right column. 
Adapted from 206 
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A protocol with optimized labeling conditions was established and is represented schematically 
in Figure 16a. Binding of Alexa Fluor fluorescent dyes to viral envelope proteins was allowed 
during 2 h incubation period on a rocker in dark at room temperature. The molar ratio of UUKV 
glycoproteins GN & GC to dye was 1 to 2.5. To purify viral particles, the virus solution was 
layered on top of a linear sucrose gradient, ranging from 15 % to 60 % sucrose (w/v). After 
ultracentrifugation for 90 minutes at 100 000 x g and 4°C, a milky band was visible at a density 
corresponding to 45 % sucrose. The band was extracted with a syringe and it was further 
analyzed to assess whether it contains infectious labeled viral particles. A transparent colored 
band, most likely comprising the unbound dye molecules, remained on top of the gradient, as 
expected. 
Infectivity of labeled virus stocks was determined on BHK-21 cells by a focus forming unit 
assay. Titers between 5x107 ffu/mL (focus forming units per milliliter) and 4x108 ffu/mL were 
obtained. In-gel fluorescence of an SDS-PAGE gel was acquired and exhibited two fluorescent 
bands corresponding to GN and GC (Figure 16b), verifying that Alexa Fluor fluorescent dyes 
successfully bound to UUKV envelope glycoproteins. Subsequent Coomassie staining 
confirmed the presence of the three major structural proteins N, GN and GC (Figure 16b). The 
absence of a fluorescent band corresponding to UUKV-N proved that Alexa Fluor fluorescent 
dyes could not access and label this protein located inside viral particles, suggesting that viral 
particles were intact. Figure 16c shows confocal imaging of UUKV-AF568 on HeLa cells. 
After binding on ice (0 mpi) viral particles formed a ring with a certain distance to the nucleus, 
indicating that UUKV-AF568 was bound to the plasma membrane. At 30 mpi a fraction of virus 
particles was present in the nuclear periphery, suggesting that UUKV-AF568 successfully 
entered HeLa cells (Figure 16c). Summarizing, integrity and efficient fluorescent labeling of 
UUKV particles was demonstrated. 
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Figure 16: UUKV labeling with Alexa Fluor succinimidyl ester dyes 
(a) UUKV particle labeled with Alexa Fluor dye (green) and schematic representation of the protocol for UUKV 
labeling with Alexa Fluor succinimidyl esters: Viral particles were semipurified through a 25% sucrose cushion 
and incubated with the Alexa Fluor dye for 2 h at room temperature (RT). The molar ratio of UUKV glycoproteins 
GN & GC to dye was 1 to 2.5. Viral suspension was loaded on a linear 15-60 % sucrose gradient and centrifuged 
for 90 minutes at 100 000 x g. The milky appearing band containing viral particles was extracted with a syringe. 
Left illustration adapted from 206 (b) Labeling of viral particles and particle integrity were analyzed under 
nonreducing conditions on SDS-PAGE for In-gel-fluorescence (acquired with Fluorescence image reader, left 
panels), and then by coomassie staining (right panels). (c) UUKV-AF568 was bound to HeLa cells on ice at a 
MOI of 2 for 1 h. After 0 minutes or 30 minutes at 37°C cells were fixed, exposed to the nuclear staining Hoechst 
and acquired with the confocal microscope. 
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10.3 The role of Rab11a in UUKV infection 
Rab11a is a small GTPase involved in recycling endosomes trafficking and believed to form a 
platform for autophagosome assembly 129. We showed that Rab11a was involved in infection 
of HeLa cells by UUKV (Figure 11a, Figure 13). To follow up on the specific function of 
Rab11a in UUKV infection we investigated its implication in the different steps of the viral life 
cycle from attachment to replication. 
10.3.1 Rab11a is involved in UUKV entry 
In a first step, we determined whether Rab11a regulated UUKV infection during the viral entry 
process (from endocytosis up to fusion) or replication. To this end, I used an assay consisting 
in bypassing virus endocytosis. This means that release of the viral genome into the cytosol did 
not rely on the virus entry pathway through the endocytic machinery (Figure 17a). Viral 
particles were bound to the cells on ice and acid-activated fusion of the viral envelope with the 
plasma membrane was induced by acidification at pH5 and 37°C for 90 seconds. To prevent 
viral particles from entering cells via the natural infection route during the remaining 6 h 
infection period, ammonium chloride (NH4Cl) was then added to the incubation medium. The 
weak base NH4Cl instantaneously neutralized the pH in host intracellular vesicular 
compartments and thereby inhibited fusion of viral particles from endosomes. 
The efficiency of the NH4Cl-containing incubation buffer was assessed by using a pH7 buffer 
for the 90 seconds treatment instead of the pH5 buffer. As illustrated in Figure 17b-c (left 
diagram), addition of 50 mM NH4Cl after pH7 treatment completely blocked infection at MOI 
4 and MOI 10, proving that 50 mM NH4Cl was sufficient to prevent UUKV infection via the 
natural infection route. Hence, 50 mM NH4Cl could be applied during the 6 h incubation period 
after pH5 treatment, to assure that only those viral particles replicated, that have entered by 
plasma membrane fusion. At MOI 4 and 10, the infection level in cells silenced for Rab11a 
could be restored to the infection level in scrambled control cells when we bypassed the entry 
pathway (Figure 17b-c). Thus, Rab11a was not required for infection after fusion. 
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Figure 17: Rab11a plays a role during UUKV entry in HeLa cells 
(a) Schematic representation of the endocytic bypass assay: Infection at pH7 occurred by receptor-mediated 
endocytosis and subsequent trafficking to acidic late endosomal compartments. Virus fusion from acidic 
compartments could be inhibited with the weak base ammonium chloride (NH4Cl). At pH5 UUKV envelope fused 
with the plasma membrane and the viral genome was released into the cytosol without the necessity of host entry 
factors. (b-c) HeLa cells were transfected with 20 nM siRNA targeting RAB11A for 72 h. UUKV was bound to 
HeLa cells on ice at a MOI of 4 (b) or 10 (c) for 1 h. Cells were exposed to pH5 or pH7 buffer for 90 seconds at 
37°C and incubated for 5 h in the presence or absence of 50 mM NH4Cl. After fixation and permeabilization, 
infected cells were immunostained for UUKV-N and analyzed by flow cytometry. 
 
The viral entry route of UUKV before fusion and virus genome release into the cytosol, can be 
subdivided into three steps: binding, internalization and endosomal transport to a compartment 
with acidic luminal pH where fusion occurs. To precisely define in which viral entry step 
Rab11a was involved, we addressed them individually. 
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10.3.2 Rab11a does not modify expression of the UUKV receptor DC-SIGN 
Following the virus entry pathway, we started by assessing UUKV receptor expression in the 
absence of Rab11a. The cell surface expression of DC-SIGN was assessed after 
immunostaining by flow cytometry. Silencing with three nonoverlapping siRNAs targeting 
RAB11A had no effect on cell surface expression of DC-SIGN in comparison to transfection 
with a scrambled siRNA control (Figure 18a-b). As expected, almost no expression could be 
detected in the parental HeLa cells (Figure 18a-b) lacking endogenous DC-SIGN expression. 
Hence, silencing Rab11a did not modify DC-SIGN expression. 
 
 
Figure 18: DC-SIGN expression was not modified on HeLa cells following Rab11a silencing 
(a) HeLa cells were transfected with 20 nM siRNA targeting RAB11A for 48 h, immunostained for DC-SIGN and 
analyzed by flow cytometry. DC-SIGN expression of single representative samples was plotted in a histogram. (b) 
The average of geometric mean values ± SD for DC-SIGN expression were normalized to scrambled siRNA, n = 
2. 
 
10.3.3 Rab11a is not involved in UUKV binding to HeLa cells 
Binding efficiency to HeLa cells was determined with fluorescently labeled viral particles by 
flow cytometry. The cells were first transfected with siRAB11A or a scrambled siRNA and 
exposed to UUKV-AF647 with MOI 0.1, 1 and 10. Binding capacity to cells silenced for 
Rab11a and transfected with a scrambled siRNA was similar and increased with increasing 
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MOIs (Figure 19a-b). These results suggested that a lack in Rab11a expression did not impact 
UUKV binding to HeLa cells. 
 
 
Figure 19: Silencing of Rab11a did not impair UUKV binding to HeLa cells 
(a) HeLa cells were transfected with 20 nM siRNA targeting RAB11A for 72 h. UUKV-AF647 was bound to the 
cells on ice for 1 h 30 minutes and analyzed by flow cytometry. Data represent the average of geometric mean 
values for AF647 expression ± SD, n = 1, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands 
for nonsignificant. (b) Virus binding of single representative samples was plotted in a histogram. 
 
10.3.4 Rab11a is not involved in internalization of UUKV particles into HeLa cells 
To study internalization of UUKV particles, we made use of the quenching effect of Trypan 
blue on green fluorescent dyes. HeLa cells were infected with UUKV-AF488 and each sample 
was acquired twice, first in absence and then in presence of Trypan blue. As Trypan blue is not 
membrane permeant, it does not enter living cells. Consequently, only the fluorescence signal 
of UUKV-AF488 on the plasma membrane can be quenched, and internalized viral particles 
still emit green fluorescence. The proportion of internalized viral particles could be calculated 
by forming the ratio of the signal after and before addition of Trypan blue.  
As a positive control UUKV-AF488 was bound to HeLa cells on ice. Under these conditions, 
addition of 0.01 % Trypan blue reduced the fluorescence signal for AF488 by 85 % (Figure 
20a). These results confirmed that the applied concentration of Trypan blue quenched the 
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fluorescence signal from UUKV-AF488 that were bound to the plasma membrane. The residual 
signal for the cells transfected with a scrambled siRNA or siRNA against Rab11a was 
considered background and subtracted from all samples (applies for Figure 20b). 
To determine the percentage of viral particles internalized into HeLa cells, infection was 
allowed for 40 minutes at 37°C after binding on ice. Addition of Trypan blue caused a relative 
reduction in AF488 fluorescence signal to 12 % in presence of a scrambled siRNA and a 
reduction to 10 % after silencing Rab11a (Figure 20b). These results indicated that the 
percentage of internalized viral particles was comparable in HeLa cells transfected with a 
scrambled or Rab11a-targeting siRNA, and suggested that Rab11a did not interfere with UUKV 
uptake. 
Binding assays (Figure 19, Figure 28) illustrated that binding of fluorescently labeled viral 
particles to cells could be detected at MOIs between 1 and 2.5. This range was considerably 
lower than the MOI 25 used for this internalization assay (Figure 20). Application of a high 
MOI could saturate the infection. Hence, nonspecific internalization mechanisms potentially 
disguised Rab11a-dependence as a rate-limiting step for viral internalization. It will therefore 
be important to repeat the internalization assay with a lower MOI. 
 
 
Figure 20: UUKV-AF488 internalization efficiency was not impacted by Rab11a silencing in HeLa cells 
(a-b) HeLa cells were transfected with 20 nM siRNA targeting RAB11A for 72 h. UUKV-AF488 was bound to the 
cells on ice at a MOI of 25 for 1 h 30 minutes. After 40 minutes at 37°C each sample was acquired by flow 
cytometry first without, then with 0.01 % TB (Trypan blue). Data represent means ± SD, n = 2, two-tailed unpaired 
t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for nonsignificant. 
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10.3.5 Rab11a silencing delays UUKV fusion 
To assess virus intracellular trafficking, a penetration kinetic was performed in the presence 
and absence of Rab11a. In this drug-addition time course, viral particles were bound to HeLa 
cells on ice and infection was allowed by a temperature shift to 37°C. NH4Cl was added at 
different time points following infection to block the fusion of all viral particles that entered 
into the endosomal system but not yet penetrated. Infection was measured by monitoring newly 
synthetized protein N after immunofluorescence staining and analysis by flow cytometry. 
According to previous results, UUKV infection was decreased by around 70 % in cells 
transfected with a siRNA targeting RAB11A compared to a scrambled control (Figure 11a, 
Figure 21). As expected, the relative infection level in cells transfected with scrambled siRNA 
was higher the later NH4Cl was added. When NH4Cl was added 80 mpi, around 40 % of the 
cells were infected relative to those not treated with NH4Cl. This was in stark contrast to cells 
silenced for Rab11a. Even when NH4Cl was added 80 mpi, a relative infection level of only 1 
% could be reached. These results indicate that downregulation of Rab11a delays productive 
intracellular trafficking of UUKV. 
 
 
Figure 21: siRAB11A delays UUKV fusion 
HeLa cells were transfected with 20 nM siRNA targeting RAB11A for 72 h. UUKV was bound to the cells on ice 
at a MOI of 0.5 for 1 h. During 6 h incubation at 37°C, NH4Cl was added after different time periods. After fixation 
and permeabilization, infected cells were immunostained for UUKV-N and analyzed by flow cytometry. 
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10.3.6 A minor fraction of UUKV-AF568 associates with eGFP-Rab11a positive vesicles 
Preceding experiments suggest Rab11a to play a role in UUKV entry. Thereupon we wanted to 
ascertain whether viral particles enter Rab11a-decorated vesicles during viral entry. Infection 
of eGFP-Rab11a WT-expressing HeLa cells was synchronized by virus binding on ice. Infected 
cells were then shifted to 37°C to permit virus entry for different periods of time. Viral particles 
were identified with the spot detector of the bioimage analysis program Icy 209 and the 
percentage of viral particles colocalizing with Rab11a in each cell was quantified, based on 
eGFP-Rab11a signal intensity within viral spots. Upon binding on ice (0 mpi) 5 % UUKV-
AF568 particles colocalized with eGFP-Rab11a (Figure 22a+c). This was considered as 
background and was therefore subtracted from all samples. After 5 minutes at 37°C, 4 % viral 
particles colocalized with eGFP-Rab11a. After 10 minutes at 37°C a plateau, amounting to 10 
% colocalization, was reached (Figure 22a+d-f). Simultaneously assessed colocalization 
between UUKV-AF568 and eGFP-LAMP1 amounted to 5 % at 0 mpi. After background 
subtraction, 51 % UUKV particles colocalize with eGFP-LAMP1 at 30 minutes after the shift 
to 37°C (Figure 22a+g-h). Taken together, these results suggest that only a minority of viral 
particles (maximum 10 %) associate with Rab11a-positive vesicles, thus a lot less than 
associating with eGFP-LAMP1. 
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Figure 22: About 10 % UUKV-AF568 colocalize with eGFP-Rab11a 
(a)  HeLa cells were transfected with an eGFP-Rab11a or eGFP-LAMP1 expression plasmid for 24 h. UUKV-
AF568 at a MOI of 0.5 was bound to the cells on ice. Cells were shifted to 37°C and NH4Cl was added after 
different periods of time. After 6 h incubation, the cells were fixed at 37°C and imaged with the confocal 
microscope. Percentage of UUKV-AF568 colocalizing with eGFP-Rab11a or eGFP-LAMP1 per cell n = 13-27 
for each sample. Data represent means ± SD, n = 2. (b-f) Representative images of HeLa cells transfected with 
eGFP-Rab11a and infected for different periods of time. (g-h) Representative images of HeLa cells transfected 
with eGFP-LAMP1 and infected for different periods of time. Scale bar = 10 µM or 1 µM on magnified panels. 
 
10.3.7 Rab11a – extending investigations to other cell lines, viruses and protein family 
members 
Up to this point all experiments investigating the role of Rab11a in viral infection were 
performed with UUKV in HeLa cells. We next investigated whether our findings were specific 
to these HeLa cells expressing DC-SIGN (HeLa). To this end, we assessed the impact of 
silencing Rab11a on infection in parental HeLa (lacking the expression of DC-SIGN), HEK 
293T, and Huh7 cells. All are known to be sensitive to UUKV 37. Cells were transfected with 
siRNA against RAB11A and then exposed to UUKV. Infected cells were subjected to 
immunofluorescence staining and analyzed by flow cytometry. Infection was decreased by 
roughly 50 to 75 %, depending on the cell line (Figure 23). 
 
Figure 23: UUKV relies on the host factor Rab11a for the infection of multiple cell lines 
Different cell lines were transfected with 20 nM siRNA targeting RAB11A for 72 h and exposed to UUKV at a 
MOI of 0.125 (HeLa), 4 (parental HeLa), 1 (HEK 293T), 0.5 (Huh7) for 6 h. In contrast to HeLa cells, parental 
HeLa cells did not express the UUKV receptor DC-SIGN. After fixation and permeabilization, infected cells were 
immunostained for UUKV-N and analyzed by flow cytometry. Data were normalized to scrambled siRNA and 
represent mean ± SD, n = 2. 
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To evaluate whether Rab11a could play a role in infectious entry of unrelated or related viruses, 
we investigated the early penetrating alphavirus Semliki Forest (SFV), the late penetrating 
orthomyxovirus Influenza A (strain Puerto Rico 8, IAV) and the phlebovirus Rift Valley fever 
(RVFV) by using RVFV ΔNSs-eGFP (Figure 24). In this RVFV strain the major virulence 
factor NSs 210 was replaced by eGFP and could therefore be used under BSL-2 conditions. 
Infection was assessed by flow cytometry as described previously (chapter 10.1.2), using eGFP 
as readout for RVFV or after immunostaining against the viral nucleoprotein (IAV-N) and 
envelope glycoprotein E2 (SFV-E2) for IAV and SFV, respectively. Upon silencing of the 
vacuolar ATPase with siATP6V1A infectivity of all viruses drops dramatically, confirming their 
dependence on vacuolar acidification for infection, as reported previously 71,211,212. Contrasting 
with IAV, SFV, and RVFV ΔNSs-eGFP, only infection by UUKV was significantly reduced 
upon Rab11a silencing, i.e. by 58 %. These results show that Rab11a does not play an important 
role in infection by IAV, SFV, and even the closely related phlebovirus RVFV. 
 
 
Figure 24: Rab11a was not important for infection by IAV, SFV and RVFV 
HeLa cells were transfected with 20 nM siRNA targeting RAB11A for 72 h and exposed to UUKV, SFV, IAV and 
RVFV ΔNSs-eGFP at a MOI of 0.1 for 6 h. After fixation and permeabilization, infected cells were immunostained 
for UUKV-N and analyzed by flow cytometry. Data were normalized to scrambled siRNA and represent mean ± 
SD, n = 2. UUKV = Uukuniemi virus, IAV = Influenza A virus, SFV = Semliki Forest virus, RVFV = Rift Valley 
fever virus. 
 
Rab11b is an isoform of Rab11a with partially overlapping functions. To evaluate its effect on 
UUKV infection, a flow cytometry-based infection assay was performed. Silencing of RAB11B 
with two nonoverlapping siRNAs, reduced UUKV-N protein replication by around 44 % and 
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58 % (Figure 25a). As positive control siRNAs targeting RAB11A and ATP6V1A significantly 
reduced UUKV infection, siRNAs were successfully delivered into HeLa cells. But assessment 
of siRAB11B silencing efficiency would be a prerequisite to conclude on the protein’s role in 
UUKV infection. A silencing approach targeting RAB11A and RAB11B simultaneously, 
reduced UUKV-N protein replication by 45 % and 72 % (Figure 25a). This effect on infection 
was not significantly different from the single siRNAs. To evaluate the effect of Rab11b 
silencing on DC-SIGN expression, cells were immunostained for DC-SIGN after siRNA 
transfection. Neither siRAB11B_1 nor siRAB11B_2 modified the DC-SIGN expression level as 
compared to the scrambled siRNA (Figure 25b). These results suggest that Rab11b was not 
involved in DC-SIGN maturation and secretion to the plasma membrane. 
 
 
Figure 25: Rab11b was involved in UUKV infection and has no effect on DC-SIGN expression in HeLa cells 
(a) HeLa cells were transfected with 10 nM siRNA targeting RAB11A, RAB11B, both, or ATP6V1A for 72 h and 
exposed to UUKV at a MOI of 0.125 for 6 h. After fixation cells were immunostained for UUKV-N and analyzed 
by flow cytometry. Data were normalized to scrambled control and represent means ± standard deviation (SD), n 
= 2 (b) HeLa cells were transfected with 10 nM siRNA targeting RAB11B for 72 h, immunostained for DC-SIGN 
and analyzed by flow cytometry. DC-SIGN expression of single representative samples was plotted in a histogram. 
n = 1. 
 
Summarizing all experiments aiming to determine the role of Rab11a in viral infections, we 
demonstrated that Rab11a played an important role in UUKV infection, most likely during 
trafficking of viral particles through the endocytic machinery. This effect was observed in 
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different cell lines and appeared specific to UUKV as compared to other tested viruses, 
including the related phlebovirus RVFV. The Rab11 subfamily member Rab11b also played an 
important role in UUKV infection. 
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10.4 The role of Atg7 in UUKV infection 
In addition to Rab11a, we also found a key autophagy-related protein that is involved in the 
phagophore elongation, Atg7 213, to be important for UUKV infection in HeLa and Huh7 cells 
(Figure 11, Figure 14). With the same approaches used to characterize the role of Rab11a in 
infection, we also investigated the importance of Atg7 in UUKV attachment, internalization, 
intracellular trafficking and replication. 
10.4.1 Atg7 is involved in UUKV entry 
As a first step we used the endocytic bypass assay to differentiate whether Atg7 was involved 
in UUKV entry or replication (Figure 17a). The classical entry pathway (at pH7) was clearly 
blocked upon addition of 50 mM NH4Cl. This assured that infection in presence of pH5 buffer 
with subsequent exchange for complete medium with NH4Cl solely resulted from viral particles 
that have entered by fusion from the plasma membrane. The N protein level upon acid-activated 
fusion (at pH5) was comparable in Huh7 control cells and Huh7 ATG7 KO cells, meaning that 
Atg7 was not required for viral replication. From these results, combined with those showing 
that knockout of ATG7 significantly impaired UUKV infection (Figure 14), we concluded that 
Atg7 is involved in UUKV entry and not viral replication. 
 
Figure 26: Atg7 played a role in UUKV entry into Huh7 cells 
UUKV was bound to Huh7 cells on ice at a MOI of 10 for 1 h. Cells were treated for 60 seconds with pH5 or pH7 
buffer at 37°C and infection was allowed for 8 h in the presence or absence of NH4Cl. After fixation and 
permeabilization, infected cells were immunostained for UUKV-N and analyzed by flow cytometry. Data 
represent mean ± SD, n = 2, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for 
nonsignificant. 
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To define during which step in viral entry Atg7 played a role, assays specifically addressing 
receptor expression, binding and internalization were performed. 
 
10.4.2 Atg7 does not perturb expression of the UUKV receptor DC-SIGN 
To assess whether Atg7 silencing impaired the expression of the UUKV receptor DC-SIGN at 
the cell surface 54, siRNA-transfected cells were immunostained against the lectin and analyzed 
by flow cytometry. Parental HeLa cells, lacking endogenous expression of DC-SIGN, were 
used as negative control. HeLa cells transfected with a scrambled siRNA were used as a positive 
control. Transfection with all three nonoverlapping siRNAs silencing ATG7 (Figure 11b) 
resulted in a DC-SIGN expression level similar to HeLa cells transfected with scrambled 
siRNAs (Figure 27a-b). These results suggest no modification of the DC-SIGN expression 
level due to silencing Atg7. Consequently, the reason for a reduced UUKV infection rate upon 
Atg7 silencing was not related to a decrease in the number of receptor molecules at the cell 
surface. 
 
Figure 27: DC-SIGN expression was not modified by siATG7 in HeLa cells 
(a) HeLa cells were transfected with 10 nM siRNA targeting ATG7 for 48 h, immunostained for DC-SIGN and 
analyzed by flow cytometry. DC-SIGN expression of single representative samples was plotted in a histogram. (b) 
The average of geometric mean values ± SD for DC-SIGN expression were normalized to scrambled siRNA, n = 
3. 
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10.4.3 Atg7 does not play a major role in UUKV binding to Huh7 cells 
The ability of viral particles to bind Huh7 cells was assessed with fluorescently labeled viral 
particles by flow cytometry. UUKV-AF488 was allowed to attach to Huh7 cells for 1 h 30 
minutes on ice. At MOI 0.1, 0.5, and 2.5, binding efficiency to Huh7 control cells and Huh7 
ATG7 KO cells was similar (Figure 28a-b). At MOI 12.5 binding efficiency to Huh7 ATG7 
KO cells was slightly decreased by 26 % (Figure 28a-b), suggesting a minor implication of 
Atg7 in UUKV attachment to Huh7 cells when high MOIs were used. However we assessed 
Atg7 silencing on UUKV infection at MOIs below 1 (Figure 11a, Figure 14a), under 
conditions in which no difference in virus binding was observed. Consequently, the Atg7-
mediated effect on infection was not due to limited binding in the range of MOIs used for 
infection. 
 
Figure 28: Atg7 had no major impact on UUKV-AF488 binding to Huh7 cells 
(a) UUKV-AF488 was bound to Huh7 cells on ice for 1 h 30 minutes and analyzed by flow cytometry. Data 
represent average geometric mean values for AF488 expression ± SD, n = 3, two-tailed unpaired t-test, ***p ≤ 
0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for nonsignificant. (b) Virus binding of single representative samples was 
plotted in a histogram. 
 
10.4.4 Atg7 is not involved in internalization of UUKV particles into Huh7 cells 
As described previously, internalization could be assessed in a Trypan blue-based infection 
assay (chapter 10.3.4). UUKV-AF488 particles were bound to Huh7 cells on ice. Addition of 
Trypan blue resulted in a quenching of the green fluorescence (Figure 29a). The residual signal 
was considered background and subtracted from all measurements. After 40 minutes warming, 
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15 % and 19 % of the bound particles were internalized into Huh7 control and ATG7 KO cells, 
respectively. Together these results indicated that Atg7 did not play a role in the uptake of 
UUKV particles. Binding assays demonstrated that application of a lower MOI between 1 and 
2.5 would have been sufficient to detect viral particles (Figure 19, Figure 28). As mentioned 
in chapter 10.3.4, application of a high MOI could disguise Atg7-dependence as a rate limiting 
step due to nonspecific internalization mechanisms. It is therefore advisable to perform this 
assay with a lower MOI. 
 
Figure 29: ATG7 knockout did not impact UUKV internalization into Huh7 cells 
(a-b) UUKV-AF488 was bound to Huh7 cells on ice at a MOI of 30 for 1 h 30 minutes. After 40 minutes at 37°C 
each sample was acquired by flow cytometry first without, then with 0.01 % Trypan blue. TB = Trypan blue. Data 
represent means ± SD, n = 2, two-tailed unpaired t-test, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for 
nonsignificant. 
 
Summarizing all experiments on the role of Atg7 in UUKV infection we demonstrated that 
Atg7 was merely involved in intracellular trafficking of viral particles. 
 
10.5 A cell line expressing blue fluorescent protein-tagged LC3 to study the 
role of autophagosomes in UUKV infection 
To follow up our investigation into a potential role of autophagy in UUKV infection, we 
established a cell line stably expressing LC3, an autophagic marker, tagged with the blue 
fluorescent protein (BFP-LC3). LC3 appears as an accumulation of punctate structures within 
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autophagic membranes, which can be visualized by fluorescence microscopy when BFP-LC3 
is expressed 131. 
10.5.1 Fluorescently labeled LC3 decorates autophagosomes in HeLa BFP-LC3 stable cell 
line 
HeLa cells stably expressing DC-SIGN were transduced with lentiviruses to stably express 
BFP-LC3. To select cells that were transduced, we used the antibiotic blasticidin as lentiviruses 
encode a resistance gene. HeLa cells presented a diffuse blue fluorescent signal and/or punctate 
structures when they were imaged with a confocal microscope (Figure 30), demonstrating 
successful transduction and expression of BFP-LC3. 
 
 
Figure 30: HeLa BFP-LC3 stable cell line heterogenously expressed LC3. 
Unsorted HeLa BFP-LC3 cells were grown on a coverslip, fixed and imaged with a wide-field fluorescent 
microscope. Scale bar = 10 µM. 
 
However, the heterogenous level of LC3 expression, from low to strong (Figure 30), made it 
difficult to quantify puncta, a typical marker for autophagic activity. To obtain a cell line 
homogenously expressing LC3 at the single cell level, low and high expressers of BFP-LC3 
were sorted by fluorescence activated cells sorting using FACS Diva (Figure 31). 
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Figure 31: Sorting subpopulations of HeLa based on BFP-LC3 expression 
From the transduced HeLa BFP-LC3 cells, clonal cell populations were sorted for low and high levels of BFP-
LC3 expression with a cell sorter. 
 
Single BFP-LC3 puncta, corresponding to autophagosomes, were better visible in cells with a 
low BFP-LC3 expression (clone C2, Figure 32a-b) than in cells with a high BFP-LC3 
expression (clone D10, Figure 32a-b). Please, note the high basal autophagic activity in HeLa 
cells. The sensitivity of the clone C2 cells to UUKV was next assessed 6 hpi, after 
immunostaining against the protein N and analysis by flow cytometry (Figure 32c). The low 
level of BFP-LC3 expressed in clone C2 cells had no adverse effect on UUKV infection 
compared to HeLa cells. Because LC3 puncta were clearly visible and susceptibility to UUKV 
infection unaltered, the clone C2 line was chosen for further experiments. 
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Figure 32: BFP-LC3 expression and UUKV infection in two expresser clones of HeLa BFP-LC3 cells 
(a) HeLa BFP-LC3 cells expressing a low (C2) or high (D10) level of BFP-LC3 were grown on a coverslip, fixed 
and imaged with a confocal microscope. Scale bar = 10 µM. (b) HeLa, HeLa BFP-LC3 C2 or D10 cells were 
analyzed by flow cytometry for blue fluorescence associated to the cells. (c) Parental HeLa or HeLa BFP-LC3 C2 
cells were exposed to UUKV at a MOI of 0.125 for 6 h. After fixation and permeabilization, infected cells were 
immunostained for UUKV-N and analyzed by flow cytometry. Data represent means ± SD, n = 1. 
 
The following experiment aimed to assess the response of HeLa BFP-LC3 C2 to activation and 
inhibition of autophagy with drugs. Rapamycin inhibits a key regulator of autophagy, mTOR, 
and thereby activates autophagy 214. Bafilomycin A1 is an inhibitor of the vacuolar proton pump 
(vATPase), necessary to establish an acidic endosomal pH, and inhibits fusion of 
autophagosomes with lysosomes 215,216. This block in a late step of the autophagic pathway 
leads to an accumulation of autophagosomes 131. Wortmannin prevents autophagosome 
formation through inhibition of phosphatidylinositol-3-kinases 217. 
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Cells exposed to the drugs were fixed and a stack of entire cells was acquired with a confocal 
microscope. Nontreated (NT) HeLa BFP-LC3 C2 cells expressed punctate structures, indicating 
a basal autophagic activity (Figure 33). Rapamycin treatment increased the number of punctate 
structures per cell, bafilomycin A1 intensified the accumulation even more (Figure 33). 
Wortmannin decreases the formation of BFP-LC3 positive vesicles (Figure 33). Altogether 
these results indicated that autophagy-targeting drugs could induce or inhibit the formation of 
BFP-positive punctate structures. 
 
Figure 33: BFP-LC3 puncta accumulate in HeLa BFP-LC3 C2 cells upon treatment with bafilomycin A1 or 
rapamycin, and are eliminated by wortmannin treatment 
HeLa BFP-LC3 C2 cells were treated for 4 h with bafilomycin A1, rapamycin or wortmannin. After fixation a z-
stack of entire cells was imaged with the confocal microscope. Images are presented as a maximum z-projection. 
BFP-LC3 (white). Scale bar = 10 µM. 
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10.5.2 The impact of siATG7 on autophagosome formation 
The following experiments were performed to investigate the level of autophagic activity upon 
Atg7 silencing. First, the silencing efficiency of siRNAs targeting ATG7 in HeLa BFP-LC3 C2 
cells was analyzed by SDS-PAGE and WB. After immunostaining, no more Atg7 expression 
was detected as a result of specific siRNA transfection with 10 nM or 50 nM of the three 
nonoverlapping siRNAs for 72 h (Figure 34). 
 
Figure 34: Atg7 was silenced by siRNA-mediated silencing in HeLa BFP-LC3 C2 cells 
HeLa BFP-LC3 C2 cells were transfected for 72 h with 10 nM or 50 nM siRNAs targeting ATG7, lysed and 
analyzed by SDS-PAGE and Western Blot (WB). 
 
BFP-LC3 puncta, which are associated with autophagosomes, were quantified in HeLa BFP-
LC3 C2 cells transfected with the three nonoverlapping siRNAs against ATG7. Punctate 
structures above a manually defined threshold were counted with the ImageJ analyze particles 
plugin after noise reduction with the Gaussian Blur function and separation of overlapping 
objects with the Watershed function. Interestingly only siATG7_2 reduced the number of BFP-
LC3 puncta per cell, while siATG7_1 and siATG7_3 did not modify the number of BFP-LC3 
puncta per cell compared to the scrambled siRNA control (Figure 34a). Addition of 100 nM 
bafilomycin A1 for 4 h increased the number of puncta in all four samples (Figure 34b). 
Infection with UUKV had no effect on BFP-LC3 puncta accumulation in the four different 
samples (Figure 34c). In summary these results indicated that only one out of the three siRNAs 
against Atg7 inhibited autophagosome formation. UUKV infection did not lead to a change in 
the number of autophagosomes per cell 16 hpi. 
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Figure 35: BFP-LC3 puncta accumulation after Atg7-silencing in HeLa BFP-LC3 C2 cells 
HeLa BFP-LC3 C2 cells were transfected with 10 nM siRNAs targeting ATG7. (a) After 72 h of incubation, cells 
were fixed or (b) treated for 4 h with 100 nM bafilomycin A1 before fixation. (c) The cells were exposed for 16 h 
to UUKV at a MOI of 0.25. After fixation, cells were imaged with a confocal microscope and the number of puncta 
per cell was quantified with the ImageJ analyze particles plugin (after noise reduction with the Gaussian Blur 
function and separation of overlapping objects with the Watershed function), n = 13-23 cells per sample. Data 
represent mean ± SD, n = 6 (mock), n = 2 (bafilomycin A1), n = 3 (UUKV), two-tailed unpaired t-test, ***p ≤ 
0.001, **p ≤ 0.01, *p ≤ 0.05, ns stands for nonsignificant. 
 
10.5.3 UUKV rarely enters autophagosomes 40 mpi 
Thus far we could demonstrate that Rab11a, a protein associated with REs and autophagy, and 
Atg7, an autophagosome elongating protein, were involved in UUKV entry. Hence, we were 
wondering whether autophagosomes played a role in UUKV entry. To assess a potential 
association between viral particles and autophagosomes, UUKV-AF568 was bound to HeLa 
BFP-LC3 C2 cells on ice and infection was permitted at 37°C. Upon binding on ice (0 mpi), 
viral particles remained bound to the plasma membrane and did not colocalize with BFP-LC3 
(Figure 36a-b). 40 minutes after the shift to 37°C, viral particles were internalized and localized 
in the nuclear periphery (Figure 36b). Only 1.5 % of the viral particles associated with BFP-
LC3-decorated vesicles (Figure 36a). The percentage of viral particles colocalizing with BFP-
LC3 could be increased 6-fold by adding NH4Cl. Neutralization of endosomal pH by this weak 
base thereby inhibits lysosomal proteolysis and leads to an accumulation of autophagosomes 
218. 
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Figure 36: UUKV-AF568 rarely associated with BFP-LC3 puncta 40 mpi 
(a) Colocalization between UUKV-AF568 and BFP-LC3 was quantified in three fields of view per sample as 
described in Figure 35. Data represent mean ± SD, n = 2. (b) UUKV-AF568 was bound to HeLa BFP-LC3 C2 
cells on ice at a MOI of 2 for 1 h. Internalization was allowed at 37°C for 40 min, NH4Cl was added 5 minutes 
following internalization in one sample. After fixation, nuclei were stained with 100 nM Vybrant Dye Cycle 
(VDC). Cells were imaged with the confocal microscope. 
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11 Discussion  
The subject of this PhD thesis is the tick-borne phlebovirus, UUKV. It is commonly used as a 
model virus for highly pathogenic RVFV, SFTSV, TOSV and HRTV. UUKV enters 
mammalian cells by receptor-mediated endocytosis and transits Rab5-positive early endosomes 
37. The viral genome is released into the cytosol from late endosomal or lysosomal 
compartments with a luminal pH inferior to 5.4 37. The details of how UUKV particles reach 
acidic compartments to release their genome into the cytosol, remain elusive. An siRNA screen 
with two genome-wide siRNA libraries (from Dharmacon and Qiagen) was previously 
performed in our lab to identify additional host factors for infectious entry and replication of 
UUKV 80. The v-SNARE VAMP3 appeared as potential host factor from both siRNA libraries. 
In-depth characterization revealed VAMP3 as an important factor for late penetration of 
UUKV. The first discovered function of VAMP3 was a role as fusion protein in recycling 
endosomes and in constitutive exocytosis of recycling vesicles 100,101. Recent studies also 
demonstrated a role in the initiation of autophagy 104 and fusion between MVBs and 
autophagosomes 105, supporting previously found convergence of the endosomal and 
autophagic pathways 106. We thus aimed to clarify the importance of the autophagic pathway in 
UUKV infection. 
 
11.1 A subset of autophagy-associated proteins is involved in UUKV 
infection 
Virus replication is highly sensitive to commonly used autophagy inhibitors such as 
wortmannin, bafilomycin A1, siRNAs against the vacuolar H
+ ATPase, NH4Cl and chloroquine 
37,54. As these perturbants all block the autophagic and the endocytic pathways, these inhibitors 
cannot be used to specifically investigate the implication of one of these pathways on UUKV 
infection. To specifically target the autophagic pathway, we decided to assess the role of several 
autophagy-associated proteins in UUKV infection. 
Autophagy is a catabolic pathway for the degradation of cytoplasmic unwanted constituents in 
lysosomes. Autophagy can specifically degrade viruses and aid establishing an innate and 
adaptive immune response counteracting viral infection, as it was reported for the two closely 
related phleboviruses RVFV and SFTSV 147,158,159. Through evolutionary competition, 
however, viruses have evolved mechanisms to circumvent antiviral autophagic mechanisms and 
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even to utilize parts of the autophagosomal machinery for their own purposes 147. Thus, 
autophagy can be pro- or antiviral. We demonstrated a proviral role of the autophagy-associated 
factors Rab11a and Atg7 in UUKV infection. Further autophagy-associated proteins such as 
Atg3, Atg5, Atg9L1, Atg14L, Atg16L1, Beclin 1, FIP200, Rab1b and WIPI1 had no clear effect 
on UUKV infection. These results illustrate that the conventional autophagy pathway was most 
likely not necessary for viral infection. UUKV rather exploits a subset of autophagy-associated 
proteins for infection. 
Rab11a, Rab1b, WIPI1 and FIP200 appeared as host factor candidates in the siRNA screens 80. 
The suggested function of Rab11a and Rab1b as host factors for UUKV infection could be 
confirmed. But despite a good silencing efficiency, Rab1b played a minor role in infection. In 
contrast, a role of FIP200 and WIPI1 in UUKV infection could not be confirmed. Because we 
did not assess siRNA-mediated silencing efficiency of FIP200 and WIPI1, no firm conclusion 
could be drawn on their involvement in infection. Deviating results in the siRNA screen and 
my experiments could have occurred due to the use of different siRNAs, resulting in inefficient 
silencing or unspecific off-target effects. 
The presence of Atg7 and Rab11a facilitated UUKV infection in different cell lines, expressing 
or not the virus entry receptor DC-SIGN 54. Hence, a tissue-specific effect can be excluded and 
the role of both proteins is not linked to viral particle internalization through DC-SIGN. We 
specifically addressed the involvement of Atg7 and Rab11a in different steps of the virus life 
cycle. We found both proteins to play a role in endosomal trafficking of viral particles. They 
had no effect on plasma membrane binding of viral particles or genome replication. 
 
11.2 Rab11 facilitates intracellular trafficking of UUKV particles to acidic 
compartments for fusion 
Small GTPases of the Rab family regulate intracellular membrane trafficking events. Bound to 
GTP, Rab proteins recruit specific effectors to regulate vesicle transport and promote tethering 
and fusion 219. Rab11a is a small GTPase that regulates recycling endosome trafficking and 
secretory pathways from the TGN to the plasma membrane 108. Additionally, Rab11a is 
proposed to regulate initiation of autophagy 129 and autophagosome-endosome fusion 200. 
The viral receptor DC-SIGN is internalized upon ligand-binding and recycled back to the 
plasma membrane after dissociation from its cargo 220. In the case of UUKV internalization, 
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DC-SIGN dissociates from UUKV in early endosomes to be recycled back to the cell surface 
54. Rab11a and Rab11b are typical regulators for recycling of different receptors such as the 
transferrin receptor 185,186,189 and mediate recycling from endosomal compartments, through 
REs to the plasma membrane 194. We illustrated that expression of DC-SIGN on the plasma 
membrane did not rely on Rab11a or Rab11b, suggesting that DC-SIGN is recycled independent 
of these small GTPases. This suggestion is in line with the report, that DC-SIGN did not 
colocalize with Rab11a during internalization and recycling in monocyte-derived dendritic cells 
221. As an alternative to the late (slow) Rab11a-dependent recycling pathway 194, an early Rab4-
dependent recycling pathway is described 193. Rab4 regulates a fast recycling from EEs directly 
to the cell surface 193. DC-SIGN could be recycled by this Rab4-dependent pathway.   
An involvement of Rab11a in viral infection was described previously 222–224. Rab11a is 
involved in various steps of the virus life cycle from prefusion steps to replication, viral particle 
assembly, exocytosis and release. We demonstrated, that Rab11a promoted endosomal 
trafficking of UUKV particles before viral RNA was released into the cytoplasm. A role of 
Rab11a in viral entry is also suggested for the mosquito-borne Japanese encephalitis virus 
(JEV) and the classical swine fever virus (CSFV), both belonging to the family of Flaviviridae 
225,226. It has to be mentioned here, that both studies did not directly assess a function of Rab11a 
in virus entry, instead viral genome replication was used as a readout for functional approaches. 
Their conclusion that Rab11a is important for viral entry, relies on an inhibition of the viral 
genome replication after Rab11a silencing or dominant negative mutant expression in 
combination with virus particle-Rab11a colocalization events during early infection 225,226. 
Interestingly, the two arboviruses UUKV and JEV transit Rab5-positive early endosomes, rely 
on Rab11a and do not require active Rab7 for productive infection 37,225. These results suggest 
that the two arboviruses utilize partially similar Rab11a-dependent and Rab7-independent entry 
pathways. Rab7 is a late endosomal marker, required for maturation of EEs to LEs 227,228 and 
fusion of LEs with LYSs 229. To study the role of Rab7 in viral infection, Rab7 mutants were 
overexpressed or silenced with specific siRNAs. Based on studies using Rab7 and Rab11a 
perturbants, several viruses are proposed to rely on one of the two proteins for infectious entry 
into mammalian cells 225,230,231. 
An interesting finding regarding Rab11a- and Rab7-dependent endosomal trafficking was 
reported for mosquito-borne DENVs 230. Acosta and colleagues demonstrate that DENV 
particles transit Rab5-positive EEs and subsequently enter either Rab11a-positive or Rab7-
positive vesicles before penetration 230. Which of the two pathways is used, depends on the 
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virus strain 230. Flaviviruses mostly rely on a mildly acidic pH for fusion, that is present in EEs 
232. DENV has a pH-threshold of 6.2 230. Viruses that fuse from EEs, typically penetrate 3 – 8 
mpi 77. Nevertheless, different DENV serotypes and strains penetrate 14 – 16 mpi 230. These 
penetration kinetics rather correspond to those of viruses fusing from LEs 77. Thus, the 
penetration kinetics suggest that DENV particles traffic beyond EEs 230. A feasible explanation 
for virus trafficking to Rab7-positive LEs or Rab11a-positive REs is the dependence on specific 
lipids 233. Effective DENV fusion to intracellular membranes relies on anionic lipids such as 
BMP and phosphatidylserine (PS) 233. Indeed, BMP is found in LEs 234, while PS is present on 
RE membranes 235, suggesting that DENV particles can fuse from Rab11a- or Rab7-positive 
compartments. 
Similar to the flaviviruses JEV and specific DENV strains, the phlebovirus UUKV transits 
Rab5-positive EEs was not affected by expression of a dominant negative Rab7 mutant 37. 
Instead, these arboviruses are suggested to rely on Rab11a for infectious entry 225,230. 
Penetration from Rab11a-positive compartments, as it is proposed for certain DENV strains 230, 
is most likely not the case for UUKV. In contrast to flaviviruses, UUKV particles rely on a 
more acidic pH for fusion, around 5.4 37. But the pH level of REs is less acidic than in EEs, 
around 6.4 235,236, thus, not suitable for UUKV penetration. Additionally, the vesicle’s lipid 
composition plays an important role in particle fusion 81. Lipid mixing to liposomes shows that 
membranous lipids of REs, such as PS, cholesterol and sphingomyelin (SM) 235 do not promote 
UUKV fusion 81. Despite no evident importance of Rab7 for infection 37, several lines of 
evidence suggest that UUKV particles fuse from acidic late endosomal compartments. The pH 
threshold for UUKV fusion is 5.4 37. Such pH levels are usually found in LEs and LYSs 75. 
UUKV fusion relies on the anionic lipid BMP 81, which is present in late endosomal 
compartments 235. Acid-activated fusion occurs 20-40 mpi 54, a timing corresponding to cargo 
reaching late endosomal compartments 75. Additionally, infectious entry relies on temperatures 
above 25°C. Temperatures below 20°C inhibit LE maturation 237. I therefore propose that 
UUKV particles traffic from Rab5-positive EEs to acidic late endosomal compartments in a 
Rab11a-dependent manner. I propose that taking this Rab11a-dependent route allows viral 
particles to enter acidic compartments in a Rab7-independent manner. A similar entry route 
could be taken by the poxvirus Vaccinia (VV). VV transits Rab11a-positive REs, and not Rab7-
positive LEs, before the virus capsid is released into the cytosol 231. VV envelope can fuse with 
the host vesicular membrane at a pH around 5.2 238, which is typical for LEs 75. Interestingly, 
UUKV and VV do not require Rab7 for trafficking, nevertheless a small fraction of UUKV and 
VV particles colocalizes with Rab7 37,231. This could be explained by the proposed Rab11a-
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dependent and Rab7-independent trafficking to acidic late endosomal compartments. Rab7-
positive late endosomal compartments and Rab11a-positive REs form big vesicles in the 
nuclear periphery 194. This location to the same cellular compartment allows to speculate about 
an interplay between the endocytic degradation pathway and the exocytosis pathway, possibly 
leading to virus particle association with Rab7, a typical marker of LEs 77. Why UUKV is 
associated with Rab7-positive vesicles, whereas Rab7 is not required for trafficking, remains to 
be elucidated. To investigate this, UUKV appears as a precious tool.  
In addition to UUKV, we also assessed the role of the vacuolar H+ ATPase and Rab11a in SFV, 
RVFV and IAV infection. Just like UUKV, the membrane fusion of SFV, RVFV and IAV is 
reported to rely on endosomal acidification 239. This was reflected by our findings that these 
viruses depended on the vacuolar H+ ATPase (ATP6V1A) for viral replication. Silencing of 
Rab11a had no major impact on replication of SFV (early penetrating virus) and IAV (late 
penetrating virus) 239,240. Overall this indicates that Rab11a silencing did not result in a block 
of the general endocytic machinery but was rather restricted to Rab11-mediated vesicular 
trafficking. SFV is suggested to penetrate from Rab5-positive EEs and does not rely on active 
Rab7 37,241,242. The pH threshold for fusion is above 6, and viral particles penetrate around 5 
mpi 242. We demonstrated that Rab11a was not involved in SFV replication, suggesting that this 
early penetration mechanism does not rely on Rab11a. Similar to UUKV, IAV particles transit 
Rab5-positive EEs 243. They reach (CD63-positive) LEs 40 mpi and fusion relies on a pH 
threshold around 5.1 239,243. It is well accepted that IAV penetrates from late endosomal 
compartments. VAMP3 and Rab11a were demonstrated to be involved in UUKV replication 
but not in IAV replication 80, indicating that the entry pathways of these two late penetrating 
viruses diverge. Early entry steps of both viruses rely on Rab5-positive EEs 37,243. Like VAMP3, 
Rab11a thus might play a role during late endocytosis. A role of Rab11a in IAV infection was 
studied previously. Rab11a transports progeny genome to the assembly site and is also involved 
in assembly of viral particles 244. In this study we only assessed earlier steps of the IAV life 
cycle up to and including replication. Hence, our demonstration that Rab11a did not play a role 
in IAV replication is not contradictory to previous reports, demonstrating an importance of 
Rab11a in postreplication steps of IAV infection. The infectivity of the late-penetrating 
phlebovirus RVFV was slightly reduced upon Rab11a silencing. This effect was less 
pronounced than for UUKV, suggesting that UUKV exhibited entry properties different from 
the closely related RVFV. Further phleboviruses will have to be tested to find out whether 
Rab11a is a host factor specific for UUKV or several genus members. 
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An additional important player in intracellular trafficking of UUKV to late endosomal 
compartments is the v-SNARE protein VAMP3 80. VAMP3 is a fusion protein in REs and 
involved in constitutive exocytosis 100,101. Yamazaki and colleagues illustrate that silencing 
VAMP3 inhibits the formation of Rab11a-positive compartments 245, raising the possibility of 
a connective function of Rab11a and VAMP3 in UUKV infection. The importance of both 
proteins in recycling endosome trafficking points towards a potential involvement of these 
compartments in UUKV intracellular trafficking. Moreover, a role of Rab11a in virus particle 
entry is not restricted to UUKV. Rab11a also promotes entry of JEV, DENV and VV into 
mammalian cells 225,230,231. Thus, I propose to use UUKV as cargo to better understand the role 
of recycling endosomes in late endosomal trafficking, a function that remains elusive and is 
potentially subverted by a number of related and unrelated viruses. UUKV transits Rab5-
positive EEs, and VAMP3-positive compartments during late endocytosis for productive entry 
37,80. Some viral particles also associate with Rab7 and more than 50 % with LAMP1-positive 
vesicles during late entry steps 37. HeLa cells stably expressing eGFP-Rab5, eGFP-VAMP3, 
eGFP-Rab7 or eGFP-LAMP1 could be established and used to follow trafficking of AF-labeled 
viral particles to these specific compartments in the presence or absence of Rab11a. 
Coimmunoprecipitation could identify Rab11a interaction partners and thereby specify the 
function of Rab11a in UUKV infection. Several Rab11a effectors that regulate activation of 
other Rab proteins, mediate vesicle transport along the cytoskeleton or fusion with the target 
membrane have been identified 108,224. Together this would help to more precisely define in 
which step of intracellular membrane trafficking Rab11a is involved. 
Besides their role in recycling endosome trafficking, Rab11a and VAMP3 are both proposed to 
be involved in the initiation of autophagy 104,110,129, pointing towards a potential involvement of 
the autophagic pathway in UUKV infection. We demonstrated that a number of key autophagy 
proteins were not important for infection, suggesting an autophagy-independent function of the 
two proteins in UUKV infection. 
To investigate whether UUKV associated with Rab11a-positive vesicles, we assessed 
colocalization between eGFP-Rab11a and UUKV-AF568. Already after binding on ice, 5 % 
viral particles colocalized with Rab11a or LAMP1. Rab11a could be close to the plasma 
membrane because it interacts with the exocytosis complex to fuse REs with the plasma 
membrane 190 and thus colocalize with membrane-bound viral particles. Newly synthesized 
LAMP1 is mainly delivered from the Golgi apparatus directly to LEs and then LYSs 246. 
However, a small fraction traffics to the plasma membrane before endocytosis and delivery to 
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LYSs 246. This fraction could be accountable for the colocalization with membrane-bound viral 
particles. Due to the presence of Rab11a and LAMP1 on or close to the plasma membrane, we 
considered the colocalization events upon viral particle binding on ice as background and 
removed them from all other samples. 
UUKV localization to Rab11a-decorated compartments in HeLa cells increased 5 mpi and 
reached a plateau 10 mpi. The level of 10 % colocalization was maintained until 30 mpi, the 
last time point investigated. UUKV was previously reported to start entering Rab5-positive 
early endosomes 5 mpi and to reach a maximum 10 mpi in A549 cells, until no longer detectable 
30 mpi 37. In the meantime, movement to Rab7-positive late endosomes occurred, reaching a 
maximum 30 – 40 mpi 37. In case of a direct role of Rab11a-decorated compartments in UUKV 
trafficking, this timing would argue for a role of Rab11a starting with early endosomal 
trafficking and proceeding to late endosomal trafficking. To exclude a misinterpretation due to 
differing entry kinetics in HeLa and A549 cells, endosomal trafficking of UUKV particles 
should be assessed in HeLa cells. Nevertheless, entry in these two cell lines should be 
comparable because functional Rab5 is important in both cell lines and internalization and 
penetration kinetics are comparable 37,54. Interestingly, colocalization of the Rab11a-dependent 
JEV, DENV and VV with Rab11a was also observed after colocalization with Rab5, further 
underlining parallels in UUKV, JEV, DENV and VV entry 225,230,231. 
Our results illustrated, that 10 % of bound or internalized UUKV particles entered Rab11a-
positive vesicles. But only a fraction of viral particles will productively infect a cell. 
Colocalization of such a small fraction therefore raises the question, whether these Rab11a-
colocalizing viral particles productively infect the cell. Or, if these Rab11a-colocalizing 
particles represent noninfectious viral particles and Rab11a indirectly promotes UUKV 
intracellular trafficking. Rab11a regulates slow recycling from endosomal compartments 
through REs back to the plasma membrane 194. With this function, viral particles could be 
recycled to the plasma membrane. Thus Rab11a-UUKV colocalization would represent a 
transport that does not result in productive infection. Perturbing Rab11a could interfere with 
the maturation of late REs and/or the fusion between REs and specific populations of 
endosomes. Under this assumption, perturbing Rab11a could indirectly impair the maturation 
of LEs that are important for UUKV entry. Otherwise, Rab11a could directly promote 
infectious entry by transporting viral particles from Rab5-positive EEs to Rab7- or LAMP1-
positive, acidic late endosomal compartments. 
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11.3 Atg7 promotes endosomal trafficking of UUKV 
Atg7 is an essential factor with E1-like enzymatic activity for the Atg12 and the LC3 ubiquitin-
like conjugation systems of the core autophagic machinery 113. Atg7 catalyzes the initial step 
for the formation of the Atg12-Atg5-Atg16L1 complex 113 and activates LC3 247. After Atg7-
mediated LC3 activation, Atg3 and the Atg12-Atg5-Atg16L1 complex catalyze LC3-
conjugation to the phospholipid PE on the phagophore membrane 248,249. LC3 then recruits 
specific substrates to the phagophore 132,133 and mediates fusion of the autophagosome with the 
lysosome 135. Summarizing, Atg7 is an important factor for recruitment of LC3 to the 
phagophore membrane. By expression of fluorescently labeled LC3, its recruitment to 
autophagosomes (from a diffuse cytosolic expression to puncta formation) can be followed by 
fluorescence microscopy. We established HeLa cells stably expressing BFP-LC3. LC3-puncta 
formation could be induced with the autophagy inducer rapamycin and the autophagic flux 
inhibitor bafilomycin A1 and LC3-puncta formation could be inhibited with the autophagosome 
formation inhibitor wortmannin, together indicating that LC3-decorated structures represent 
autophagosomes. Hence, HeLa cells stably expressing BFP-LC3 could be used to follow 
autophagosome formation. Of note, we also detected a high level of LC3-positive vesicles in 
nonstimulated cells. This is in accordance with literature, describing a high basal autophagic 
activity in HeLa cells 250. We demonstrated that three nonoverlapping siRNAs targeting ATG7 
efficiently silenced Atg7. siATG7_2 reduced the number of LC3 puncta per cell. This reduction 
in LC3 puncta formation reflects the importance of Atg7 in LC3-lipidation 247. Surprisingly, 
siATG7_1 and siATG7_3 had no effect on autophagosome formation. Maybe, the remaining 
Atg7 expression after silencing with these two siRNAs was sufficient to sustain autophagic 
activity. Despite differential effects on autophagosome formation, all three siRNAs reduced 
UUKV infection by around 50 %. These results indicated that the role of Atg7 in UUKV 
infection was not related to autophagy, because no matter if autophagosome formation was 
obstructed or not, Atg7-silencing reduced infection to a similar extent. Atg3 and Atg7 are 
consecutively involved in the same step of the autophagic pathway. The enzymatic activity of 
both proteins is required for lipidation of the autophagy marker LC3 130. We demonstrated, that 
only Atg7 played a role in UUKV infection, while knockdown or knockout of Atg3 did not 
affect infection. An involvement of Atg7 and not of Atg3 further supports the suggestion of an 
autophagy-independent role of Atg7 in UUKV infection. To my knowledge, a proviral function 
of Atg7 in viral infection that is not related to autophagy, has not been reported thus far. 
Autophagy-independent functions of Atg7 are the secretion of lysosomal contents in osteoclasts 
251 or interaction with p53 upon nutrient deprivation, that leads to a cell cycle arrest 252. But 
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neither would directly explain how Atg7 could function in UUKV endosomal trafficking – thus 
leaving UUKV as an interesting tool to study autophagy-independent cell biological functions 
of Atg7 and a likely role in endocytic trafficking. 
After autophagy inhibition with wortmannin, some LC3-puncta were present in HeLa BFP-LC3 
cells. We could alternatively explain why siATG7_2 reduced the number of LC3 puncta per cell 
and siATG7_1 and siATG7_3 did not by speculating that these unspecific aggregates form due 
to overexpression of BFP-LC3. With this hypothesis siATG7_2 would (in addition to silencing 
Atg7) unspecifically silence a host factor that blocks BFP-LC3 expression and thereby prevent 
aggregate formation. To circumvent this uncertainty, I propose to select a HeLa BFP-LC3 clone 
that expresses a lower level of BFP-LC3 to prevent unspecific aggregation. Another option 
would be to assess LC3 distribution in HeLa cells with an antibody, binding endogenous LC3. 
To assess, whether UUKV particles entered autophagosomes, HeLa cells stably expressing 
BFP-LC3 were used. UUKV did not associate with LC3-decorated autophagic vesicles 40 mpi 
in nontreated cells. NH4Cl-mediated accumulation of autophagosomes led to 9 % UUKV-
autophagosome colocalization. Lysosomotropic weak bases such as NH4Cl do not affect LE 
generation or transport of cargo to LYSs 253–255. NH4Cl elevates the endosomal pH and thereby 
inhibits lysosomal proteolysis 218 and blocks UUKV penetration into the cytosol 37. 
Consequently, in the presence of NH4Cl viral particles accumulate in compartments from which 
they usually fuse. Endosomes can fuse with autophagosomes to form amphisomes, thereby 
bridging the endosomal and the autophagosomal pathway 106. If UUKV fusion-competent 
compartments fuse with LC3-decorated autophagosomes, UUKV could colocalize with LC3, 
even if viral particles do not require LC3-positive compartments for infectious entry. For future 
experiments it will thus be important to assess earlier time points for UUKV-autophagosome 
colocalization. 
The suggestion that UUKV follows the classic endocytic pathway for entry into mammalian 
cells is contradicted by the following finding: Studies with Rab7 mutants revealed that this 
GTPase, which is important for EE to LE maturation 227,228 and LE LYS fusion 229, is most 
likely not involved in infection 37. How viral particles reach acidic endosomal compartments 
for fusion remains elusive. We showed that Atg7 was involved in endosomal trafficking of 
UUKV particles and propose an autophagy-independent function. Such unconventional 
functions of Atg7 are scarcely studied. Mauthe and colleagues demonstrated that autophagy-
related proteins have numerous unconventional functions, which remain to be identified 256,257. 
Therefore we hypothesize a role of Atg7 in UUKV intracellular trafficking to reach acidic 
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endosomal compartments. To characterize this potential role of Atg7 in endosomal trafficking, 
I propose to assess the distribution of the EE marker Rab5 and the RE marker Rab11a in 
presence and absence of Atg7. A potential perturbance of endosomal distribution could point 
to an Atg7-mediated function. 
ATG7 knockout in Huh7 cells reduced UUKV replication by 50 %. Thus, UUKV infection was 
reduced but ongoing in absence of Atg7. These results could be explained in two different ways. 
One is that functionally redundant proteins substitute the function of Atg7. Since isoforms of 
Atg7 are not identified and we do not know the precise function of Atg7 in UUKV infection, I 
cannot judge whether a functionally redundant protein can substitute Atg7. The partial 
dependence on Atg7 could also signify that UUKV used distinct entry pathways within one cell 
line. The use of diverse endocytic pathways was demonstrated previously. A small fraction of 
UUKV particles is internalized clathrin-dependently while additional clathrin-independent 
uptake mechanisms exist 37. It is thus imaginable that UUKV particles can follow distinct 
endocytic pathways to traffic towards acidic endosomal compartments for fusion. 
Similarly, Rab11a knockdown, also allowed UUKV replication. In the case of silencing, a 
residual protein expression could be sufficient for viral replication. Since a residual protein 
expression was detected after siRNA-mediated silencing by WB this is a reasonable 
explanation. As explained above, UUKV could enter mammalian cells by using distinct entry 
pathways. Apart from that, proteins with a similar function could substitute Rab11a. Indeed, 
two isoforms are identified, Rab11b or Rab25 (Rab11c), which have overlapping functions with 
Rab11a in the control of trafficking through REs 185–187. Despite its expression, which is 
restricted to brain, heart and testes 183, a low level of RAB11B mRNA could be detected in HeLa 
cells 80. Comparable to Rab11a, Rab11b silencing reduced UUKV infection by at least 45 %. 
Thus Rab11b is likely involved in UUKV infection and could indeed substitute the function of 
Rab11a. Knockdown of Rab11b with siRNAs remains to be assessed by WB. Interestingly, 
silencing the two isoforms simultaneously neither enhanced nor weakened the inhibitory effect 
on UUKV infection. In this case, Rab25 should also be included in the study as it could 
substitute the function of Rab11a and Rab11b. 
 
11.4 Perspectives 
This study opens up perspectives for investigations into different directions. The first more 
fundamental research-based perspective would be to identify the specific function of Rab11a 
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and Atg7 in UUKV infection. The thesis in hand already gives us an interesting insight into 
Atg7 function. Mainly known as a key autophagy protein, its function in UUKV infection seems 
to be independent of autophagosome formation. UUKV thereby represents a suitable and 
powerful cargo to study a potentially unknown mechanism of action of Atg7 in endosomal 
trafficking. Rab11a is proposed to promote entry of RNA viruses (UUKV, JEV, DENV) and a 
DNA virus (VV) into mammalian cells 225,230,231. This role for infection with diverse acid-
dependent viruses suggests a more general function of Rab11a in endocytosis that deserves to 
be defined more precisely. (Assays are proposed in the discussion above.) 
Our findings should contribute to a better understanding of phlebovirus infection and 
consequently, to the development of new antiviral strategies. In the future, it would therefore 
be interesting to shed light on the entry pathway of highly pathogenic phleboviruses by 
extending the model that we have established for UUKV to TOSV, HRTV and SFTSV. The 
here identified host factors for UUKV infection, Rab11a and Rab11b can indeed be targeted 
with small molecules and therefore represent an interesting drug target 258. Investigations in this 
study are limited to the cell culture adapted human adenocarcinoma cell line HeLa, the human 
hepatocellular carcinoma cell line Huh7 and the human embryonic kidney cell line HEK 293, 
all representing an artificial system. Natural infection occurs via an arthropod bite that results 
in the injection of the virus into the dermis. Dermal DCs are present in this anatomical site of 
infection and possibly rank among the first encountered cells 40. It was demonstrated that 
UUKV and RVFV replicate in immature DCs 54. Utilizing primary DCs to study virus entry 
could give a clue whether our findings are applicable to more relevant cells. The degree of 
complexity in the regulation of endocytic processes increases in polarized cells as compared to 
nonpolarized cells that were used in this project 259,260. In addition, endocytic trafficking is 
differentially regulated in two- and three-dimensional tissue culture 261. Such distinctions most 
likely impact virus entry as well. To recapitulate architectural features of the intact tissue, it 
would thus be interesting to study infection in polarized three-dimensional cell culture. 
Moreover, it was demonstrated in our lab that glycosylation patterns of mammalian-derived 
UUKV particles are different from tick cell-derived particles 38. In this study, exclusively 
mammalian-derived virus stocks were used. As different glycosylation patterns could well 
influence receptor recognition and the initial infection, I propose to additionally assess vector-
derived virus stocks.  
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12 Publications and Contributions 
12.1 Peer-reviewed publications 
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12.3 Contributions to this thesis 
All data shown in this thesis were acquired and analyzed by me, if not stated here otherwise. 
Michelle Yee performed UUKV infection assays, bypass assays, binding assays and 
internalization assays and with Huh7 knockout cell lines (Figure 14, Figure 26, Figure 28, 
Figure 29). 
Ann-Kathrin Mehnert performed the drug-addition time course with UUKV (Figure 21). 
Hannah Fleckenstein developed the analysis method for LC3 puncta quantification with 
ImageJ and Jana Koch assessed Atg7 expression and quantified puncta in siATG7 transfected 
HeLa cells (Figure 34, Figure 35). 
Malte Simon performed part of the UUKV infection assays with siFIP200 and siWIPI1 (Figure 
11b). 
Sven Blobner performed part of the UUKV infection assays with siRAB11A and siRAB1B 
(Figure 11a). 
Dr. Keisuke Tabata produced Huh7 knockout cell lines. 
Dr. Verena Lang transduced HeLa DC-SIGN cells with the BFP-LC3 encoding construct. 
Dr. Monika Langlotz sorted the HeLa DC-SIGN BFP-LC3 cell lines. 
Dr. Susann Kummer produced Influenza A virus. 
Nicole Cordes produced RVFV ΔNSs-eGFP. 
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